SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '006'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4L_D_DCFD1853_1 (ADENOSINE DEAMINASE) |
3azq | AMINOPEPTIDASE (Streptomycesmorookaense) | 5 / 12 | ALA A 315GLY A 314GLU A 285HIS A 311ASP A 330 | NoneSO4 A1006 ( 3.8A)NoneNoneNone | 1.42A | 1a4lD-3azqA:undetectable | 1a4lD-3azqA:19.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1AZM_A_AZMA262_1 (CARBONIC ANHYDRASE I) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 8 | HIS B2264HIS B2260HIS B2290HIS B2150 | CUO B9006 (-3.2A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.3A) | 1.01A | 1azmA-4bedB:undetectable | 1azmA-4bedB:9.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1BU5_B_RBFB302_1 (PROTEIN (FLAVODOXIN)) |
2z2z | TK-SUBTILISINPRECURSOR (Thermococcuskodakarensis) | 4 / 8 | THR A 323ASN A 264ASP A 379GLY A 266 | NoneNone CA A1006 (-3.0A)None | 0.95A | 1bu5B-2z2zA:2.2 | 1bu5B-2z2zA:17.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1BZM_A_MZMA262_1 (CARBONIC ANHYDRASE I) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 8 | HIS B2264HIS B2260HIS B2290HIS B2150 | CUO B9006 (-3.2A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.3A) | 0.98A | 1bzmA-4bedB:undetectable | 1bzmA-4bedB:9.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9S_N_TRPN81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 10 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.93A | 1c9sN-4yswA:undetectable1c9sO-4yswA:undetectable | 1c9sN-4yswA:5.061c9sO-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9S_P_TRPP81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 11 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.91A | 1c9sP-4yswA:undetectable1c9sQ-4yswA:undetectable | 1c9sP-4yswA:5.061c9sQ-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9S_V_TRPV81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 5 / 10 | GLY A 915GLY A1006HIS A 884ALA A1079ILE A1007 | NoneNoneNoneTEI A3006 ( 3.8A)None | 0.97A | 1c9sL-1n5xA:0.01c9sV-1n5xA:0.0 | 1c9sL-1n5xA:4.961c9sV-1n5xA:4.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9S_V_TRPV81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 10 | GLY A 915GLY A1006HIS A 884ALA A1079ILE A1007 | BCT A3006 (-3.9A)NoneNoneURC A3007 (-3.4A)None | 0.91A | 1c9sL-4yswA:undetectable1c9sV-4yswA:undetectable | 1c9sL-4yswA:5.061c9sV-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1CEB_A_AMHA90_1 (PLASMINOGEN) |
2vc2 | INTEGRIN ALPHA-IIB (Homosapiens) | 4 / 7 | ARG A 400ASP A 373ASP A 365TYR A 371 | None CA A2006 (-2.4A) CA A2006 (-3.4A)None | 1.29A | 1cebA-2vc2A:undetectable | 1cebA-2vc2A:9.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DZ8_A_CAMA503_0 (CYTOCHROME P450-CAM) |
4pd4 | CYTOCHROME B (Saccharomycescerevisiae) | 5 / 9 | PHE C 329LEU C 302VAL C 301THR C 308VAL C 367 | 3PH C4006 ( 4.9A)NoneNoneNoneNone | 1.44A | 1dz8A-4pd4C:undetectable | 1dz8A-4pd4C:20.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1E9Y_B_HAEB800_1 (UREASE SUBUNIT BETA) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 4 / 5 | HIS A 55HIS A 174HIS A 233ASP A 306 | ZN A1004 (-3.2A) ZN A1006 (-3.2A) ZN A1006 (-3.4A) ZN A1004 (-2.9A) | 0.59A | 1e9yB-2z00A:21.0 | 1e9yB-2z00A:22.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EI6_A_PPFA410_1 (PHOSPHONOACETATEHYDROLASE) |
2iuc | ALKALINE PHOSPHATASE (AntarcticbacteriumTAB5) | 4 / 5 | ASP B 259HIS B 263HIS B 302HIS B 337 | ZN B1006 (-2.1A) ZN B1006 (-3.2A) ZN B1007 (-3.1A) ZN B1006 ( 3.3A) | 0.38A | 1ei6A-2iucB:17.3 | 1ei6A-2iucB:21.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EI6_C_PPFC413_1 (PHOSPHONOACETATEHYDROLASE) |
2iuc | ALKALINE PHOSPHATASE (AntarcticbacteriumTAB5) | 5 / 8 | ASP B 43ASP B 259HIS B 263HIS B 302HIS B 337 | ZN B1007 ( 2.1A) ZN B1006 (-2.1A) ZN B1006 (-3.2A) ZN B1007 (-3.1A) ZN B1006 ( 3.3A) | 0.45A | 1ei6C-2iucB:17.2 | 1ei6C-2iucB:21.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FIQ_C_SALC1335_1 (XANTHINE OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 8 / 8 | GLU A 802LEU A 873ARG A 880PHE A 914THR A1010VAL A1011LEU A1014ALA A1079 | TEI A3006 ( 3.2A)TEI A3006 (-4.8A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)TEI A3006 (-4.8A)NoneTEI A3006 ( 3.8A) | 0.30A | 1fiqC-1n5xA:64.9 | 1fiqC-1n5xA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FO4_A_SALA3005_1 (XANTHINEDEHYDROGENASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 9 / 9 | GLU A 802LEU A 873SER A 876ARG A 880PHE A 914THR A1010VAL A1011LEU A1014ALA A1079 | TEI A3006 ( 3.2A)TEI A3006 (-4.8A)TEI A3006 (-3.5A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)TEI A3006 (-4.8A)NoneTEI A3006 ( 3.8A) | 0.34A | 1fo4A-1n5xA:46.6 | 1fo4A-1n5xA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FO4_A_SALA3005_1 (XANTHINEDEHYDROGENASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 5 / 9 | SER A 876PHE A 914VAL A1011LEU A1014ALA A1078 | TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-4.8A)NoneMOS A3004 (-3.0A) | 1.20A | 1fo4A-1n5xA:46.6 | 1fo4A-1n5xA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FO4_B_SALB4005_1 (XANTHINEDEHYDROGENASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 7 / 7 | GLU A 802SER A 876ARG A 880PHE A 914THR A1010VAL A1011ALA A1078 | TEI A3006 ( 3.2A)TEI A3006 (-3.5A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)TEI A3006 (-4.8A)MOS A3004 (-3.0A) | 0.27A | 1fo4B-1n5xA:46.5 | 1fo4B-1n5xA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FO4_B_SALB4005_1 (XANTHINEDEHYDROGENASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 4 / 7 | SER A 876PHE A 914VAL A1011ALA A1079 | TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-4.8A)TEI A3006 ( 3.8A) | 1.02A | 1fo4B-1n5xA:46.5 | 1fo4B-1n5xA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FWE_C_HAEC989_1 (UREASE) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 5 / 6 | HIS A 55HIS A 57HIS A 174HIS A 233ASP A 306 | ZN A1004 (-3.2A) ZN A1004 (-3.4A) ZN A1006 (-3.2A) ZN A1006 (-3.4A) ZN A1004 (-2.9A) | 0.63A | 1fweC-2z00A:21.8 | 1fweC-2z00A:23.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GSE_A_EAAA224_1 (GLUTATHIONETRANSFERASE) |
4zu9 | ELONGATION FACTORSELB (Aquifexaeolicus) | 5 / 12 | ARG A 198GLY A 199LEU A 246VAL A 223ALA A 236 | CYS A2006 (-3.8A)NoneNoneNoneNone | 1.16A | 1gseA-4zu9A:undetectable | 1gseA-4zu9A:18.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTF_Q_TRPQ81_0 (TRP RNA-BINDINGATTENUATION PROTEIN(TRAP)) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 11 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.92A | 1gtfQ-4yswA:undetectable1gtfR-4yswA:undetectable | 1gtfQ-4yswA:5.061gtfR-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTF_S_TRPS81_0 (TRP RNA-BINDINGATTENUATION PROTEIN(TRAP)) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 11 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.92A | 1gtfS-4yswA:undetectable1gtfT-4yswA:undetectable | 1gtfS-4yswA:5.061gtfT-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTI_B_CCSB47_0 (GLUTATHIONES-TRANSFERASE) |
6brs | PUTATIVE ZINCPROTEASE (Pectobacteriumatrosepticum) | 4 / 7 | LEU A 582LEU A 568GLY A 628LEU A 623 | HG A1006 (-4.6A)NoneNoneNone | 0.74A | 1gtiB-6brsA:undetectable | 1gtiB-6brsA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_T_TRPT81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 11 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.94A | 1gtnT-4yswA:undetectable1gtnU-4yswA:undetectable | 1gtnT-4yswA:5.061gtnU-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_V_TRPV81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 5 / 12 | GLY A 915GLY A1006HIS A 884ALA A1079ILE A1007 | NoneNoneNoneTEI A3006 ( 3.8A)None | 0.98A | 1gtnL-1n5xA:0.01gtnV-1n5xA:0.0 | 1gtnL-1n5xA:4.961gtnV-1n5xA:4.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_V_TRPV81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 12 | GLY A 915GLY A1006HIS A 884ALA A1079ILE A1007 | BCT A3006 (-3.9A)NoneNoneURC A3007 (-3.4A)None | 0.93A | 1gtnL-4yswA:undetectable1gtnV-4yswA:undetectable | 1gtnL-4yswA:5.061gtnV-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GXS_A_BEZA601_0 (P-(S)-HYDROXYMANDELONITRILE LYASE CHAINAP-(S)-HYDROXYMANDELONITRILE LYASE CHAINB) |
5b4x | REELIN (Musmusculus) | 5 / 7 | GLY A2504PRO A2511ASP A2567HIS A2489ALA A2636 | NoneNAG A4006 (-4.4A)NoneNoneNone | 1.45A | 1gxsA-5b4xA:undetectable1gxsB-5b4xA:undetectable | 1gxsA-5b4xA:16.581gxsB-5b4xA:14.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1I2W_A_CFXA1300_2 (BETA-LACTAMASE) |
5wmm | NRPS (Micromonosporasp.ML1) | 4 / 5 | TYR A 217LEU A 285THR A 301ARG A 319 | NoneNoneNone CA A1006 (-4.0A) | 1.30A | 1i2wA-5wmmA:undetectable | 1i2wA-5wmmA:14.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IA0_B_TXLB502_1 (TUBULIN BETA CHAIN) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 5 / 12 | HIS A 174THR A 258ARG A 283ARG A 59GLY A 325 | ZN A1006 (-3.2A)NoneNoneNoneNone | 1.26A | 1ia0B-2z00A:2.6 | 1ia0B-2z00A:20.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ITU_B_CILB452_1 (RENAL DIPEPTIDASE) |
1jhd | SULFATEADENYLYLTRANSFERASE (Sulfur-oxidizingendosymbiontofRiftiapachyptila) | 5 / 12 | HIS A 205TYR A 390TYR A 391VAL A 242PRO A 239 | BR A2001 ( 4.3A)NoneNoneNone BR A2006 ( 4.7A) | 1.41A | 1ituB-1jhdA:undetectable | 1ituB-1jhdA:20.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JR1_B_MOAB1333_1 (INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE 2) |
2g8s | GLUCOSE/SORBOSONEDEHYDROGENASES (Escherichiacoli) | 4 / 8 | ASP A 67GLY A 145GLY A 198GLN A 197 | NoneNoneEDO A3006 ( 4.5A)EDO A3006 ( 4.6A) | 0.80A | 1jr1B-2g8sA:undetectable | 1jr1B-2g8sA:23.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MT1_G_AG2G7003_1 (PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE BETACHAINPYRUVOYL-DEPENDENTARGININEDECARBOXYLASE ALPHACHAIN) |
1n2m | PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE (Methanocaldococcusjannaschii) | 4 / 6 | LEU A 31ASP A 35LEU A 38GLY A 44 | MRD A7006 ( 4.2A)NoneNoneNone | 0.15A | 1mt1G-1n2mA:3.41mt1J-1n2mA:18.3 | 1mt1G-1n2mA:100.001mt1J-1n2mA:67.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MT1_K_AG2K7002_1 (PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE ALPHACHAINPYRUVOYL-DEPENDENTARGININEDECARBOXYLASE BETACHAIN) |
1n2m | PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE (Methanocaldococcusjannaschii) | 4 / 7 | LEU A 31ASP A 35LEU A 38GLY A 44 | MRD A7006 ( 4.2A)NoneNoneNone | 0.19A | 1mt1H-1n2mA:18.11mt1K-1n2mA:3.2 | 1mt1H-1n2mA:67.881mt1K-1n2mA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MZ9_A_VDYA1002_4 (CARTILAGE OLIGOMERICMATRIX PROTEIN) |
2r6f | EXCINUCLEASE ABCSUBUNIT A (Geobacillusstearothermophilus) | 4 / 5 | LEU A 772CYH A 736ALA A 738CYH A 739 | None ZN A1006 (-2.3A) ZN A1006 ( 4.2A) ZN A1006 (-2.3A) | 0.99A | 1mz9D-2r6fA:undetectable | 1mz9D-2r6fA:5.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1N13_D_AG2D7015_1 (PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE ALPHACHAINPYRUVOYL-DEPENDENTARGININEDECARBOXYLASE BETACHAIN) |
1n2m | PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE (Methanocaldococcusjannaschii) | 4 / 7 | LEU A 31ASP A 35LEU A 38GLY A 44 | MRD A7006 ( 4.2A)NoneNoneNone | 0.19A | 1n13D-1n2mA:18.21n13E-1n2mA:3.0 | 1n13D-1n2mA:67.881n13E-1n2mA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1N13_F_AG2F7016_1 (PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE BETACHAINPYRUVOYL-DEPENDENTARGININEDECARBOXYLASE ALPHACHAIN) |
1n2m | PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE (Methanocaldococcusjannaschii) | 4 / 8 | LEU A 31ASP A 35LEU A 38GLY A 44 | MRD A7006 ( 4.2A)NoneNoneNone | 0.20A | 1n13A-1n2mA:3.71n13F-1n2mA:18.4 | 1n13A-1n2mA:100.001n13F-1n2mA:67.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1N13_H_AG2H7012_1 (PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE ALPHACHAINPYRUVOYL-DEPENDENTARGININEDECARBOXYLASE BETACHAIN) |
1n2m | PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE (Methanocaldococcusjannaschii) | 4 / 6 | LEU A 31ASP A 35LEU A 38GLY A 44 | MRD A7006 ( 4.2A)NoneNoneNone | 0.24A | 1n13H-1n2mA:18.31n13K-1n2mA:3.3 | 1n13H-1n2mA:67.881n13K-1n2mA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1N13_J_AG2J7013_1 (PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE BETACHAINPYRUVOYL-DEPENDENTARGININEDECARBOXYLASE ALPHACHAIN) |
1n2m | PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE (Methanocaldococcusjannaschii) | 4 / 7 | LEU A 31ASP A 35LEU A 38GLY A 44 | MRD A7006 ( 4.2A)NoneNoneNone | 0.20A | 1n13G-1n2mA:3.41n13J-1n2mA:18.5 | 1n13G-1n2mA:100.001n13J-1n2mA:67.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N2X_B_SAMB402_0 (S-ADENOSYL-METHYLTRANSFERASE MRAW) |
4ncn | EUKARYOTICTRANSLATIONINITIATION FACTOR5B-LIKE PROTEIN (Chaetomiumthermophilum) | 5 / 12 | THR A 537GLY A 535GLY A 530GLY A 555ASN A 547 | MG A1002 ( 3.1A)GTP A1001 (-3.1A)None NA A1003 ( 4.6A)GOL A1006 (-3.8A) | 0.92A | 1n2xB-4ncnA:undetectable | 1n2xB-4ncnA:21.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OE1_A_CUA502_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
1g5b | SERINE/THREONINEPROTEIN PHOSPHATASE (EscherichiavirusLambda) | 3 / 3 | ASP A 49HIS A 76HIS A 22 | MN A1005 (-2.6A)SO4 A3001 (-3.9A) MN A1006 (-3.4A) | 0.63A | 1oe1A-1g5bA:undetectable | 1oe1A-1g5bA:23.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OE2_A_CUA502_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
2vqa | SLL1358 PROTEIN (Synechocystissp.PCC6803) | 3 / 3 | GLU A 290HIS A 329HIS A 285 | MN A1006 ( 2.3A) MN A1006 (-3.5A) MN A1006 ( 3.5A) | 0.66A | 1oe2A-2vqaA:undetectable | 1oe2A-2vqaA:21.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OE3_A_CUA502_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
1g5b | SERINE/THREONINEPROTEIN PHOSPHATASE (EscherichiavirusLambda) | 3 / 3 | ASP A 49HIS A 76HIS A 22 | MN A1005 (-2.6A)SO4 A3001 (-3.9A) MN A1006 (-3.4A) | 0.61A | 1oe3A-1g5bA:undetectable | 1oe3A-1g5bA:23.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OG5_B_SWFB502_1 (CYTOCHROME P450 2C9) |
6ffh | METABOTROPICGLUTAMATE RECEPTOR5,ENDOLYSIN (EscherichiavirusT4;Homosapiens) | 5 / 12 | ILE A1791PHE A1788LEU A1786ALA A1787LEU A1808 | NoneD7W A4006 (-3.1A)OLA A4007 ( 4.3A)OLA A4007 ( 4.6A)None | 1.22A | 1og5B-6ffhA:0.9 | 1og5B-6ffhA:9.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ONI_D_BEZD507_0 (14.5 KDATRANSLATIONALINHIBITOR PROTEIN) |
2z2x | TK-SUBTILISIN (Thermococcuskodakarensis) | 4 / 7 | ALA A 227ILE A 218ILE A 348GLU A 229 | CA A1006 (-4.9A) CA A1004 (-4.9A)None CA A1006 (-2.2A) | 0.92A | 1oniD-2z2xA:undetectable1oniF-2z2xA:1.1 | 1oniD-2z2xA:20.341oniF-2z2xA:20.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OS2_D_HAED574_1 (MACROPHAGEMETALLOELASTASE) |
2vqa | SLL1358 PROTEIN (Synechocystissp.PCC6803) | 4 / 4 | HIS A 329GLU A 290HIS A 285HIS A 283 | MN A1006 (-3.5A) MN A1006 ( 2.3A) MN A1006 ( 3.5A) MN A1006 ( 3.4A) | 1.14A | 1os2D-2vqaA:undetectable | 1os2D-2vqaA:17.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P5Z_B_AR3B304_1 (DEOXYCYTIDINE KINASE) |
3oky | PLEXIN-A2 (Musmusculus) | 5 / 12 | ILE A 172GLU A 123LEU A 139ARG A 174ASP A 179 | GOL A2006 (-3.9A)NoneNoneGOL A2006 (-4.1A)None | 1.42A | 1p5zB-3okyA:undetectable | 1p5zB-3okyA:16.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6K_A_MTLA870_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2d1g | ACID PHOSPHATASE (Francisellatularensis) | 4 / 8 | SER A 281ASN A 275GLN A 347ASP A 283 | NoneNoneETX A1006 (-3.5A)None | 1.30A | 1p6kA-2d1gA:undetectable | 1p6kA-2d1gA:19.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6K_B_MTLB871_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2d1g | ACID PHOSPHATASE (Francisellatularensis) | 4 / 8 | SER A 281ASN A 275GLN A 347ASP A 283 | NoneNoneETX A1006 (-3.5A)None | 1.27A | 1p6kB-2d1gA:undetectable | 1p6kB-2d1gA:19.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q23_B_FUAB703_2 (CHLORAMPHENICOLACETYLTRANSFERASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | VAL B2136ALA B2137HIS B2122 | NoneNoneCUO B9006 (-3.2A) | 0.69A | 1q23C-4bedB:undetectable | 1q23C-4bedB:8.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q23_G_FUAG708_2 (CHLORAMPHENICOLACETYLTRANSFERASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | VAL B2136ALA B2137HIS B2122 | NoneNoneCUO B9006 (-3.2A) | 0.58A | 1q23H-4bedB:undetectable | 1q23H-4bedB:8.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q23_I_FUAI707_1 (CHLORAMPHENICOLACETYLTRANSFERASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | VAL B2136ALA B2137HIS B2122 | NoneNoneCUO B9006 (-3.2A) | 0.70A | 1q23G-4bedB:undetectable | 1q23G-4bedB:8.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q23_K_FUAK712_2 (CHLORAMPHENICOLACETYLTRANSFERASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | VAL B2136ALA B2137HIS B2122 | NoneNoneCUO B9006 (-3.2A) | 0.77A | 1q23L-4bedB:undetectable | 1q23L-4bedB:8.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q23_L_FUAL710_1 (CHLORAMPHENICOLACETYLTRANSFERASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | VAL B2136ALA B2137HIS B2122 | NoneNoneCUO B9006 (-3.2A) | 0.63A | 1q23J-4bedB:undetectable | 1q23J-4bedB:8.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RJO_A_CUA701_0 (PHENYLETHYLAMINEOXIDASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | HIS B2291HIS B2260HIS B2150 | CUO B9006 (-3.5A)CUO B9006 (-3.2A)CUO B9006 (-3.3A) | 0.70A | 1rjoA-4bedB:undetectable | 1rjoA-4bedB:17.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS6_A_MTLA870_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2d1g | ACID PHOSPHATASE (Francisellatularensis) | 4 / 8 | SER A 281ASN A 275GLN A 347ASP A 283 | NoneNoneETX A1006 (-3.5A)None | 1.34A | 1rs6A-2d1gA:undetectable | 1rs6A-2d1gA:19.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS6_B_MTLB871_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2d1g | ACID PHOSPHATASE (Francisellatularensis) | 4 / 8 | SER A 281ASN A 275GLN A 347ASP A 283 | NoneNoneETX A1006 (-3.5A)None | 1.32A | 1rs6B-2d1gA:undetectable | 1rs6B-2d1gA:19.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS7_B_MTLB871_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2d1g | ACID PHOSPHATASE (Francisellatularensis) | 4 / 8 | SER A 281ASN A 275GLN A 347ASP A 283 | NoneNoneETX A1006 (-3.5A)None | 1.30A | 1rs7B-2d1gA:undetectable | 1rs7B-2d1gA:19.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RXC_B_URFB2011_1 (URIDINEPHOSPHORYLASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 4 / 8 | THR A 499GLY A 495GLN A 665ARG A 865 | MG A1006 ( 3.3A)ADP A1004 ( 3.2A)ALF A1005 (-3.0A)ALF A1005 (-3.1A) | 0.92A | 1rxcB-2xzoA:undetectable | 1rxcB-2xzoA:18.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RXC_I_URFI2041_1 (URIDINEPHOSPHORYLASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 4 / 8 | THR A 499GLY A 495GLN A 665ARG A 865 | MG A1006 ( 3.3A)ADP A1004 ( 3.2A)ALF A1005 (-3.0A)ALF A1005 (-3.1A) | 0.88A | 1rxcI-2xzoA:undetectable | 1rxcI-2xzoA:18.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1T03_P_TFOP822_1 (POL POLYPROTEINSYNTHETICOLIGONUCLEOTIDEPRIMER) |
5jjr | GENOME POLYPROTEIN (Denguevirus) | 4 / 7 | ASP A 533ASP A 663ASP A 664LYS A 689 | MG A1006 (-3.0A)None MG A1006 (-2.7A)None | 1.47A | 1t03A-5jjrA:4.4 | 1t03A-5jjrA:21.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TLS_B_C2FB266_0 (THYMIDYLATE SYNTHASE) |
2z2z | TK-SUBTILISINPRECURSOR (Thermococcuskodakarensis) | 5 / 12 | ILE A 291LEU A 373GLY A 374VAL A 386ALA A 370 | NoneNone CA A1006 ( 4.5A)NoneNone | 1.15A | 1tlsB-2z2zA:undetectable | 1tlsB-2z2zA:20.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TUB_B_TXLB501_1 (TUBULIN) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 5 / 12 | HIS A 174THR A 258ARG A 283ARG A 59GLY A 325 | ZN A1006 (-3.2A)NoneNoneNoneNone | 1.26A | 1tubB-2z00A:1.9 | 1tubB-2z00A:20.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UOB_A_PNNA1311_0 (DEACETOXYCEPHALOSPORIN C SYNTHETASE) |
2vqa | SLL1358 PROTEIN (Synechocystissp.PCC6803) | 5 / 12 | HIS A 283LEU A 301HIS A 329VAL A 343PHE A 345 | MN A1006 ( 3.4A)None MN A1006 (-3.5A)NoneNone | 0.77A | 1uobA-2vqaA:3.9 | 1uobA-2vqaA:23.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_O_TRPO81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 12 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.94A | 1utdO-4yswA:undetectable1utdP-4yswA:undetectable | 1utdO-4yswA:5.061utdP-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_P_TRPP81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 11 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.93A | 1utdP-4yswA:undetectable1utdQ-4yswA:undetectable | 1utdP-4yswA:5.061utdQ-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_S_TRPS81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 5 / 11 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneTEI A3006 ( 3.8A)NoneNone | 0.96A | 1utdS-1n5xA:undetectable1utdT-1n5xA:undetectable | 1utdS-1n5xA:4.961utdT-1n5xA:4.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_S_TRPS81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 11 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.92A | 1utdS-4yswA:undetectable1utdT-4yswA:undetectable | 1utdS-4yswA:5.061utdT-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_U_TRPU81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 10 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.95A | 1utdU-4yswA:undetectable1utdV-4yswA:undetectable | 1utdU-4yswA:5.061utdV-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTZ_A_HAEA1267_1 (MACROPHAGEMETALLOELASTASE) |
2vqa | SLL1358 PROTEIN (Synechocystissp.PCC6803) | 4 / 4 | HIS A 329GLU A 290HIS A 285HIS A 283 | MN A1006 (-3.5A) MN A1006 ( 2.3A) MN A1006 ( 3.5A) MN A1006 ( 3.4A) | 1.16A | 1utzA-2vqaA:undetectable | 1utzA-2vqaA:16.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1W2Z_B_CUB701_0 (AMINE OXIDASE,COPPER CONTAINING) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | HIS B2291HIS B2260HIS B2150 | CUO B9006 (-3.5A)CUO B9006 (-3.2A)CUO B9006 (-3.3A) | 0.71A | 1w2zB-4bedB:undetectable | 1w2zB-4bedB:16.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1W2Z_C_CUC701_0 (AMINE OXIDASE,COPPER CONTAINING) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | HIS B2291HIS B2260HIS B2150 | CUO B9006 (-3.5A)CUO B9006 (-3.2A)CUO B9006 (-3.3A) | 0.71A | 1w2zC-4bedB:undetectable | 1w2zC-4bedB:16.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1W2Z_D_CUD701_0 (AMINE OXIDASE,COPPER CONTAINING) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | HIS B2291HIS B2260HIS B2150 | CUO B9006 (-3.5A)CUO B9006 (-3.2A)CUO B9006 (-3.3A) | 0.69A | 1w2zD-4bedB:undetectable | 1w2zD-4bedB:16.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1WYG_A_SALA4005_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 10 / 10 | GLU A 802LEU A 873SER A 876ARG A 880PHE A 914PHE A1009THR A1010ALA A1078ALA A1079GLU A1261 | TEI A3006 ( 3.2A)TEI A3006 (-4.8A)TEI A3006 (-3.5A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-4.8A)TEI A3006 (-2.8A)MOS A3004 (-3.0A)TEI A3006 ( 3.8A)MOS A3004 ( 3.7A) | 0.45A | 1wygA-1n5xA:44.6 | 1wygA-1n5xA:86.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Y93_A_HAEA301_1 (MACROPHAGEMETALLOELASTASE) |
2vqa | SLL1358 PROTEIN (Synechocystissp.PCC6803) | 4 / 6 | ILE A 272HIS A 283HIS A 329HIS A 285 | None MN A1006 ( 3.4A) MN A1006 (-3.5A) MN A1006 ( 3.5A) | 0.89A | 1y93A-2vqaA:undetectable | 1y93A-2vqaA:17.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Y93_A_HAEA301_1 (MACROPHAGEMETALLOELASTASE) |
2vqa | SLL1358 PROTEIN (Synechocystissp.PCC6803) | 5 / 6 | ILE A 272HIS A 329GLU A 290HIS A 285HIS A 283 | None MN A1006 (-3.5A) MN A1006 ( 2.3A) MN A1006 ( 3.5A) MN A1006 ( 3.4A) | 1.07A | 1y93A-2vqaA:undetectable | 1y93A-2vqaA:17.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YVM_A_TMGA501_1 (METHIONINEAMINOPEPTIDASE) |
4aay | AROB (Rhizobiumsp.NT-26) | 4 / 7 | CYH B 103TYR B 168CYH B 121HIS B 124 | FES B2006 (-2.3A)NoneFES B2006 (-2.2A)FES B2006 (-3.0A) | 1.38A | 1yvmA-4aayB:undetectable | 1yvmA-4aayB:23.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZZQ_A_MTLA870_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2d1g | ACID PHOSPHATASE (Francisellatularensis) | 4 / 8 | SER A 281ASN A 275GLN A 347ASP A 283 | NoneNoneETX A1006 (-3.5A)None | 1.30A | 1zzqA-2d1gA:undetectable | 1zzqA-2d1gA:19.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZZQ_B_MTLB871_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2d1g | ACID PHOSPHATASE (Francisellatularensis) | 4 / 8 | SER A 281ASN A 275GLN A 347ASP A 283 | NoneNoneETX A1006 (-3.5A)None | 1.28A | 1zzqB-2d1gA:undetectable | 1zzqB-2d1gA:19.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZZU_A_MTLA870_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2d1g | ACID PHOSPHATASE (Francisellatularensis) | 4 / 8 | SER A 281ASN A 275GLN A 347ASP A 283 | NoneNoneETX A1006 (-3.5A)None | 1.28A | 1zzuA-2d1gA:0.5 | 1zzuA-2d1gA:19.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZZU_B_MTLB871_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2d1g | ACID PHOSPHATASE (Francisellatularensis) | 4 / 8 | SER A 281ASN A 275GLN A 347ASP A 283 | NoneNoneETX A1006 (-3.5A)None | 1.28A | 1zzuB-2d1gA:undetectable | 1zzuB-2d1gA:19.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2A3C_B_PNXB2434_1 (CHITINASE) |
2okx | RHAMNOSIDASE B (Bacillussp.GL1) | 4 / 6 | TRP A 900PHE A 539SER A 538ARG A 540 | GOL A3006 (-4.3A)NoneNoneNone | 1.29A | 2a3cB-2okxA:undetectable | 2a3cB-2okxA:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AZQ_A_PCFA954_0 (CATECHOL1,2-DIOXYGENASE) |
2no5 | (S)-2-HALOACIDDEHALOGENASE IVA (Burkholderiacepacia) | 5 / 9 | LEU A 139ALA A 101TYR A 98LEU A 216LEU A 95 | NoneNoneSO4 A1011 ( 4.9A)SO4 A1006 ( 3.4A)None | 1.39A | 2azqA-2no5A:undetectable | 2azqA-2no5A:21.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2B60_B_RITB100_1 (GAG-POL POLYPROTEIN) |
2z2z | TK-SUBTILISINPRECURSOR (Thermococcuskodakarensis) | 5 / 12 | ALA A 380ASP A 379ILE A 291GLY A 283ALA A 267 | None CA A1006 (-3.0A)NoneNoneNone | 0.90A | 2b60A-2z2zA:undetectable | 2b60A-2z2zA:12.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_A_ZMRA1478_1 (NEURAMINIDASE) |
2no5 | (S)-2-HALOACIDDEHALOGENASE IVA (Burkholderiacepacia) | 4 / 7 | SER A 215ASP A 100SER A 217ASN A 214 | SO4 A1006 ( 2.8A)SO4 A1006 ( 3.7A)SO4 A1006 ( 4.4A)None | 1.11A | 2cmlA-2no5A:undetectable | 2cmlA-2no5A:22.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_B_ZMRB2478_1 (NEURAMINIDASE) |
2no5 | (S)-2-HALOACIDDEHALOGENASE IVA (Burkholderiacepacia) | 4 / 8 | SER A 215ASP A 100SER A 217ASN A 214 | SO4 A1006 ( 2.8A)SO4 A1006 ( 3.7A)SO4 A1006 ( 4.4A)None | 1.02A | 2cmlB-2no5A:undetectable | 2cmlB-2no5A:22.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2E1Q_A_SALA2006_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 6 / 6 | ARG A 880PHE A 914THR A1010VAL A1011LEU A1014ALA A1079 | TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)TEI A3006 (-4.8A)NoneTEI A3006 ( 3.8A) | 0.30A | 2e1qA-1n5xA:45.7 | 2e1qA-1n5xA:89.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2E1Q_B_SALB3006_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 4 / 4 | ARG A 880PHE A 914THR A1010ALA A1079 | TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)TEI A3006 ( 3.8A) | 0.26A | 2e1qB-1n5xA:45.7 | 2e1qB-1n5xA:89.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2E1Q_C_SALC4006_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 6 / 6 | ARG A 880PHE A 914THR A1010VAL A1011LEU A1014ALA A1079 | TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)TEI A3006 (-4.8A)NoneTEI A3006 ( 3.8A) | 0.26A | 2e1qC-1n5xA:45.7 | 2e1qC-1n5xA:89.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2E1Q_D_SALD5006_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 5 / 5 | ARG A 880PHE A 914THR A1010LEU A1014ALA A1079 | TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)NoneTEI A3006 ( 3.8A) | 0.21A | 2e1qD-1n5xA:45.7 | 2e1qD-1n5xA:89.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FB2_A_SAMA501_0 (MOLYBDENUM COFACTORBIOSYNTHESIS PROTEINA) |
4okd | ISOAMYLASE (Chlamydomonasreinhardtii) | 4 / 8 | THR A 383GLU A 313THR A 333VAL A 202 | NoneGLC A1006 (-4.7A)NoneNone | 1.13A | 2fb2A-4okdA:3.2 | 2fb2A-4okdA:16.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FQE_A_CUA603_0 (BLUE COPPER OXIDASECUEO) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 4 | HIS B2260HIS B2150HIS B2291HIS B2290 | CUO B9006 (-3.2A)CUO B9006 (-3.3A)CUO B9006 (-3.5A)None | 1.37A | 2fqeA-4bedB:undetectable | 2fqeA-4bedB:15.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HRE_B_CHDB701_0 (FERROCHELATASE) |
4zmh | UNCHARACTERIZEDPROTEIN (Saccharophagusdegradans) | 3 / 3 | LYS A 380GLY A 434PRO A 435 | ACT A1007 ( 3.6A)GOL A1006 ( 2.9A)None | 0.89A | 2hreB-4zmhA:undetectable | 2hreB-4zmhA:16.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IGT_A_SAMA1001_0 (SAM DEPENDENTMETHYLTRANSFERASE) |
4wqe | THIOSULFATEDEHYDROGENASE (Allochromatiumvinosum) | 5 / 12 | SER A 100ALA A 193PRO A 182GLY A 46GLY A 44 | SO3 A1006 ( 2.6A)SO3 A1006 (-4.2A)HEC A1002 (-4.6A)NoneNone | 1.14A | 2igtA-4wqeA:undetectable | 2igtA-4wqeA:21.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IGT_C_SAMC1003_0 (SAM DEPENDENTMETHYLTRANSFERASE) |
5y0m | - (-) | 5 / 12 | TYR A 146ALA A 185SER A 186GLY A 182TYR A 112 | GOL A1006 ( 4.8A)None CL A1008 ( 4.5A)NoneNone | 1.24A | 2igtC-5y0mA:undetectable | 2igtC-5y0mA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IWK_A_CUA1599_0 (NITROUS OXIDEREDUCTASE) |
1vrq | SARCOSINE OXIDASEDELTA SUBUNIT (Corynebacteriumsp.U-96) | 3 / 3 | CYH D 6CYH D 63HIS D 59 | ZN D1006 (-2.4A) ZN D1006 (-2.4A) ZN D1006 (-3.2A) | 0.67A | 2iwkA-1vrqD:2.2 | 2iwkA-1vrqD:8.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IWK_A_CUA1599_0 (NITROUS OXIDEREDUCTASE) |
1vrq | SARCOSINE OXIDASEDELTA SUBUNIT (Corynebacteriumsp.U-96) | 3 / 3 | CYH D 9CYH D 63HIS D 59 | ZN D1006 (-2.3A) ZN D1006 (-2.4A) ZN D1006 (-3.2A) | 0.60A | 2iwkA-1vrqD:2.2 | 2iwkA-1vrqD:8.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IWK_B_CUB1599_0 (NITROUS OXIDEREDUCTASE) |
1vrq | SARCOSINE OXIDASEDELTA SUBUNIT (Corynebacteriumsp.U-96) | 3 / 3 | CYH D 6CYH D 63HIS D 59 | ZN D1006 (-2.4A) ZN D1006 (-2.4A) ZN D1006 (-3.2A) | 0.68A | 2iwkB-1vrqD:2.1 | 2iwkB-1vrqD:8.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IWK_B_CUB1599_0 (NITROUS OXIDEREDUCTASE) |
1vrq | SARCOSINE OXIDASEDELTA SUBUNIT (Corynebacteriumsp.U-96) | 3 / 3 | CYH D 9CYH D 63HIS D 59 | ZN D1006 (-2.3A) ZN D1006 (-2.4A) ZN D1006 (-3.2A) | 0.57A | 2iwkB-1vrqD:2.1 | 2iwkB-1vrqD:8.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NO6_A_ETVA302_1 (DEOXYCYTIDINE KINASE) |
3oky | PLEXIN-A2 (Musmusculus) | 5 / 12 | ILE A 172GLU A 123LEU A 139ARG A 174ASP A 179 | GOL A2006 (-3.9A)NoneNoneGOL A2006 (-4.1A)None | 1.37A | 2no6A-3okyA:undetectable | 2no6A-3okyA:17.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NO6_B_ETVB302_1 (DEOXYCYTIDINE KINASE) |
3oky | PLEXIN-A2 (Musmusculus) | 5 / 11 | ILE A 172GLU A 123LEU A 139ARG A 174ASP A 179 | GOL A2006 (-3.9A)NoneNoneGOL A2006 (-4.1A)None | 1.39A | 2no6B-3okyA:0.0 | 2no6B-3okyA:17.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NOA_B_3TCB302_1 (DEOXYCYTIDINE KINASE) |
3oky | PLEXIN-A2 (Musmusculus) | 5 / 11 | ILE A 172GLU A 123LEU A 139ARG A 174ASP A 179 | GOL A2006 (-3.9A)NoneNoneGOL A2006 (-4.1A)None | 1.37A | 2noaB-3okyA:undetectable | 2noaB-3okyA:17.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OQE_A_CUA801_0 (PEROXISOMAL COPPERAMINE OXIDASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | HIS B2291HIS B2260HIS B2150 | CUO B9006 (-3.5A)CUO B9006 (-3.2A)CUO B9006 (-3.3A) | 0.72A | 2oqeA-4bedB:undetectable | 2oqeA-4bedB:17.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OQE_B_CUB801_0 (PEROXISOMAL COPPERAMINE OXIDASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | HIS B2291HIS B2260HIS B2150 | CUO B9006 (-3.5A)CUO B9006 (-3.2A)CUO B9006 (-3.3A) | 0.71A | 2oqeB-4bedB:undetectable | 2oqeB-4bedB:17.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OQE_C_CUC801_0 (PEROXISOMAL COPPERAMINE OXIDASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | HIS B2291HIS B2260HIS B2150 | CUO B9006 (-3.5A)CUO B9006 (-3.2A)CUO B9006 (-3.3A) | 0.72A | 2oqeC-4bedB:undetectable | 2oqeC-4bedB:17.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OQE_D_CUD801_0 (PEROXISOMAL COPPERAMINE OXIDASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | HIS B2291HIS B2260HIS B2150 | CUO B9006 (-3.5A)CUO B9006 (-3.2A)CUO B9006 (-3.3A) | 0.71A | 2oqeD-4bedB:undetectable | 2oqeD-4bedB:17.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OQE_F_CUF801_0 (PEROXISOMAL COPPERAMINE OXIDASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | HIS B2291HIS B2260HIS B2150 | CUO B9006 (-3.5A)CUO B9006 (-3.2A)CUO B9006 (-3.3A) | 0.73A | 2oqeF-4bedB:undetectable | 2oqeF-4bedB:17.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OW9_B_HAEB502_1 (COLLAGENASE 3) |
2vqa | SLL1358 PROTEIN (Synechocystissp.PCC6803) | 4 / 4 | HIS A 329GLU A 290HIS A 285HIS A 283 | MN A1006 (-3.5A) MN A1006 ( 2.3A) MN A1006 ( 3.5A) MN A1006 ( 3.4A) | 1.15A | 2ow9B-2vqaA:undetectable | 2ow9B-2vqaA:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OZR_C_HAEC3001_1 (COLLAGENASE 3) |
2vqa | SLL1358 PROTEIN (Synechocystissp.PCC6803) | 4 / 4 | HIS A 329GLU A 290HIS A 285HIS A 283 | MN A1006 (-3.5A) MN A1006 ( 2.3A) MN A1006 ( 3.5A) MN A1006 ( 3.4A) | 1.14A | 2ozrC-2vqaA:undetectable | 2ozrC-2vqaA:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OZR_D_HAED3002_1 (COLLAGENASE 3) |
2vqa | SLL1358 PROTEIN (Synechocystissp.PCC6803) | 4 / 4 | HIS A 329GLU A 290HIS A 285HIS A 283 | MN A1006 (-3.5A) MN A1006 ( 2.3A) MN A1006 ( 3.5A) MN A1006 ( 3.4A) | 1.11A | 2ozrD-2vqaA:undetectable | 2ozrD-2vqaA:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2P16_A_GG2A298_2 (COAGULATION FACTOR X(EC 3.4.21.6)(STUART FACTOR)(STUART-PROWERFACTOR)) |
3edv | SPECTRIN BETA CHAIN,BRAIN 1 (Homosapiens) | 3 / 3 | ARG A1741GLU A1738GLN A1737 | MG A1006 ( 3.9A)None MG A1006 ( 4.5A) | 1.09A | 2p16A-3edvA:undetectable | 2p16A-3edvA:23.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2PGR_A_DCFA501_1 (ADENOSINE DEAMINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 12 | HIS B2260HIS B2264ASP B2284HIS B2291HIS B2150 | CUO B9006 (-3.2A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.5A)CUO B9006 (-3.3A) | 0.91A | 2pgrA-4bedB:undetectable | 2pgrA-4bedB:12.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q0I_A_BEZA990_0 (QUINOLONE SIGNALRESPONSE PROTEIN) |
5wjm | CADHERIN-23 (Musmusculus) | 4 / 8 | ASP A1892ASP A1931GLU A1929SER A1838 | CA A2006 (-3.2A) CA A2005 ( 2.7A)NoneNone | 1.12A | 2q0iA-5wjmA:undetectable | 2q0iA-5wjmA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QL8_B_BEZB143_0 (PUTATIVE REDOXPROTEIN) |
3n6u | LYSR TYPE REGULATOROF TSAMBCD (Comamonastestosteroni) | 4 / 6 | TYR A 130THR A 147ALA A 145PRO A 198 | NoneNoneNoneACT A1006 (-3.7A) | 1.31A | 2ql8A-3n6uA:undetectable2ql8B-3n6uA:undetectable | 2ql8A-3n6uA:19.912ql8B-3n6uA:19.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QQC_E_AG2E671_1 (PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE (EC4.1.1.19) (PVLARGDC)) |
1n2m | PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE (Methanocaldococcusjannaschii) | 4 / 7 | LEU A 31ASP A 35LEU A 38GLY A 44 | MRD A7006 ( 4.2A)NoneNoneNone | 0.23A | 2qqcD-1n2mA:18.42qqcE-1n2mA:3.0 | 2qqcD-1n2mA:99.112qqcE-1n2mA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QQC_K_AG2K671_1 (PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE (EC4.1.1.19) (PVLARGDC)) |
1n2m | PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE (Methanocaldococcusjannaschii) | 4 / 8 | LEU A 31ASP A 35LEU A 38GLY A 44 | MRD A7006 ( 4.2A)NoneNoneNone | 0.21A | 2qqcH-1n2mA:18.42qqcK-1n2mA:3.3 | 2qqcH-1n2mA:99.112qqcK-1n2mA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QQD_B_AG2B671_1 (PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE (EC4.1.1.19) (PVLARGDC)) |
1n2m | PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE (Methanocaldococcusjannaschii) | 4 / 8 | LEU A 31ASP A 35LEU A 38GLY A 44 | MRD A7006 ( 4.2A)NoneNoneNone | 0.22A | 2qqdB-1n2mA:18.52qqdC-1n2mA:29.7 | 2qqdB-1n2mA:100.002qqdC-1n2mA:98.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QX6_A_ML1A233_1 (RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE[QUINONE]) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 4 / 6 | PHE A1009ILE A1085GLY A1035GLY A1034 | TEI A3006 (-4.8A)NoneNoneNone | 0.78A | 2qx6A-1n5xA:undetectable2qx6B-1n5xA:undetectable | 2qx6A-1n5xA:10.512qx6B-1n5xA:10.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2UY4_A_AZMA1311_1 (ENDOCHITINASE) |
2z2x | TK-SUBTILISIN (Thermococcuskodakarensis) | 5 / 9 | GLY A 221ALA A 220GLU A 229GLN A 110TYR A 180 | NoneNone CA A1006 (-2.2A) CA A1006 (-3.0A)None | 1.07A | 2uy4A-2z2xA:undetectable | 2uy4A-2z2xA:23.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2V0Z_C_C41C1328_1 (RENIN) |
3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) | 7 / 12 | ASP A 32GLY A 34SER A 35TYR A 75ASP A 215GLY A 217SER A 219 | 006 A 330 (-2.8A)006 A 330 (-3.2A)006 A 330 (-4.5A)006 A 330 (-4.3A)006 A 330 (-2.8A)006 A 330 (-3.4A)GOL A 332 ( 2.5A) | 0.60A | 2v0zC-3qs1A:41.4 | 2v0zC-3qs1A:35.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2V0Z_O_C41O1327_1 (RENIN) |
3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) | 6 / 12 | ASP A 32GLY A 34ALA A 111ASP A 215GLY A 217SER A 219 | 006 A 330 (-2.8A)006 A 330 (-3.2A)None006 A 330 (-2.8A)006 A 330 (-3.4A)GOL A 332 ( 2.5A) | 0.78A | 2v0zO-3qs1A:41.0 | 2v0zO-3qs1A:35.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2V0Z_O_C41O1327_2 (RENIN) |
3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) | 4 / 8 | TYR A 15SER A 35TYR A 75SER A 77 | None006 A 330 (-4.5A)006 A 330 (-4.3A)006 A 330 (-2.1A) | 0.93A | 2v0zO-3qs1A:41.0 | 2v0zO-3qs1A:35.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2WKO_F_CUF154_0 (SUPEROXIDE DISMUTASE[CU-ZN]) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 5 | HIS B2260HIS B2264VAL B2294HIS B2291 | CUO B9006 (-3.2A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.5A) | 1.03A | 2wkoF-4bedB:undetectable | 2wkoF-4bedB:6.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2WX2_B_TPFB1460_1 (LANOSTEROL14-ALPHA-DEMETHYLASE) |
5umu | FACT COMPLEX SUBUNITSPT16 (Homosapiens) | 4 / 8 | TYR A 864MET A 906THR A 894LEU A 842 | NoneNoneFMT A1006 (-3.7A)FMT A1003 ( 3.5A) | 0.78A | 2wx2B-5umuA:undetectable | 2wx2B-5umuA:10.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XTK_B_AZMB1339_1 (CLASS III CHITINASECHIA1) |
2z2x | TK-SUBTILISIN (Thermococcuskodakarensis) | 5 / 10 | GLY A 221ALA A 220GLU A 229GLN A 110TYR A 180 | NoneNone CA A1006 (-2.2A) CA A1006 (-3.0A)None | 1.04A | 2xtkB-2z2xA:undetectable | 2xtkB-2z2xA:23.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XXG_A_CUA1338_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
1g5b | SERINE/THREONINEPROTEIN PHOSPHATASE (EscherichiavirusLambda) | 3 / 3 | ASP A 49HIS A 76HIS A 22 | MN A1005 (-2.6A)SO4 A3001 (-3.9A) MN A1006 (-3.4A) | 0.65A | 2xxgA-1g5bA:undetectable | 2xxgA-1g5bA:23.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XXG_C_CUC1339_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
1g5b | SERINE/THREONINEPROTEIN PHOSPHATASE (EscherichiavirusLambda) | 3 / 3 | ASP A 49HIS A 76HIS A 22 | MN A1005 (-2.6A)SO4 A3001 (-3.9A) MN A1006 (-3.4A) | 0.66A | 2xxgC-1g5bA:undetectable | 2xxgC-1g5bA:23.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XZ5_D_ACHD1211_0 (SOLUBLEACETYLCHOLINERECEPTOR) |
4aay | AROB (Rhizobiumsp.NT-26) | 4 / 8 | GLN B 143TYR B 168SER B 126CYH B 121 | NoneNoneFES B2006 (-2.9A)FES B2006 (-2.2A) | 1.20A | 2xz5C-4aayB:undetectable2xz5D-4aayB:undetectable | 2xz5C-4aayB:19.632xz5D-4aayB:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y6R_B_CTCB1385_0 (TETX2 PROTEIN) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 4 / 8 | GLN A 918PHE A 914GLY A 915GLY A 800 | NoneTEI A3006 (-3.6A)NoneNone | 0.84A | 2y6rB-1n5xA:undetectable | 2y6rB-1n5xA:14.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y6R_B_CTCB1385_0 (TETX2 PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 4 / 8 | GLN A 918PHE A 914GLY A 915GLY A 800 | BCT A3006 (-3.0A)URC A3007 ( 3.4A)BCT A3006 (-3.9A)None | 0.81A | 2y6rB-4yswA:undetectable | 2y6rB-4yswA:14.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_A_ZMRA1776_2 (NEURAMINIDASE A) |
1hv5 | STROMELYSIN 3 (Musmusculus) | 4 / 6 | ARG A 191ASP A 158ILE A 159LEU A 138 | NoneCPS A5006 ( 4.9A)NoneNone | 0.96A | 2ya7A-1hv5A:0.0 | 2ya7A-1hv5A:15.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_B_ZMRB1776_2 (NEURAMINIDASE A) |
1hv5 | STROMELYSIN 3 (Musmusculus) | 4 / 6 | ARG A 191ASP A 158ILE A 159LEU A 138 | NoneCPS A5006 ( 4.9A)NoneNone | 0.94A | 2ya7B-1hv5A:0.0 | 2ya7B-1hv5A:15.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_C_ZMRC1776_2 (NEURAMINIDASE A) |
1hv5 | STROMELYSIN 3 (Musmusculus) | 4 / 6 | ARG A 191ASP A 158ILE A 159TYR A 261 | NoneCPS A5006 ( 4.9A)NoneNone | 1.23A | 2ya7C-1hv5A:undetectable | 2ya7C-1hv5A:15.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_D_ZMRD1776_2 (NEURAMINIDASE A) |
1hv5 | STROMELYSIN 3 (Musmusculus) | 4 / 6 | ARG A 191ASP A 158ILE A 159LEU A 138 | NoneCPS A5006 ( 4.9A)NoneNone | 0.94A | 2ya7D-1hv5A:0.0 | 2ya7D-1hv5A:15.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YFB_A_ACTA501_0 (METHYL-ACCEPTINGCHEMOTAXISTRANSDUCER) |
1xkd | ISOCITRATEDEHYDROGENASE (Aeropyrumpernix) | 4 / 7 | ASP A 315VAL A 138ARG A 136ILE A 157 | CA A1006 (-2.9A)NoneICT A1002 (-3.0A)None | 1.01A | 2yfbA-1xkdA:0.0 | 2yfbA-1xkdA:21.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YFB_B_ACTB501_0 (METHYL-ACCEPTINGCHEMOTAXISTRANSDUCER) |
1xkd | ISOCITRATEDEHYDROGENASE (Aeropyrumpernix) | 4 / 6 | ASP A 315VAL A 138ARG A 136ILE A 157 | CA A1006 (-2.9A)NoneICT A1002 (-3.0A)None | 1.05A | 2yfbB-1xkdA:undetectable | 2yfbB-1xkdA:21.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YGQ_A_PCFA1275_0 (WNT INHIBITORYFACTOR 1) |
4pd4 | CYTOCHROME B (Saccharomycescerevisiae) | 5 / 12 | ILE C 125LEU C 275ILE C 122PHE C 121PHE C 333 | AOQ C4003 ( 4.4A)AOQ C4003 (-3.8A)None3PH C4006 ( 4.6A)3PH C4006 (-4.1A) | 1.01A | 2ygqA-4pd4C:undetectable | 2ygqA-4pd4C:21.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YVL_C_SAMC604_1 (HYPOTHETICAL PROTEIN) |
5chc | DMSO REDUCTASEFAMILY TYPE IIENZYME,MOLYBDOPTERINSUBUNIT (Azospiraoryzae) | 4 / 4 | GLY A 448GLU A 447ASP A 184TYR A 708 | NoneNoneNoneEDO A1006 (-4.2A) | 1.30A | 2yvlC-5chcA:1.8 | 2yvlC-5chcA:14.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZJ0_B_2FAB500_2 (ADENOSYLHOMOCYSTEINASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 4 / 5 | LEU A 873GLN A 767THR A 803THR A1010 | TEI A3006 (-4.8A)MOS A3004 (-3.8A)NoneTEI A3006 (-2.8A) | 1.07A | 2zj0B-1n5xA:undetectable | 2zj0B-1n5xA:17.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZWE_B_DAHB98_1 (TYROSINASEMELC) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 11 | HIS B2122HIS B2141HIS B2260ASN B2261HIS B2264 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A) | 0.88A | 2zweA-4bedB:21.32zweB-4bedB:undetectable | 2zweA-4bedB:10.392zweB-4bedB:5.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZWF_B_DAHB98_1 (TYROSINASEMELC) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 11 | HIS B2122HIS B2141HIS B2260ASN B2261HIS B2264 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A) | 0.91A | 2zwfA-4bedB:21.32zwfB-4bedB:undetectable | 2zwfA-4bedB:10.392zwfB-4bedB:5.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZWG_B_DAHB98_1 (TYROSINASEMELC) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 11 | HIS B2122HIS B2141HIS B2260ASN B2261HIS B2264 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A) | 0.91A | 2zwgA-4bedB:23.12zwgB-4bedB:undetectable | 2zwgA-4bedB:10.392zwgB-4bedB:5.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZWG_B_DAHB98_1 (TYROSINASEMELC) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 11 | HIS B2122HIS B2150HIS B2260ASN B2261HIS B2264 | CUO B9006 (-3.2A)CUO B9006 (-3.3A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A) | 1.46A | 2zwgA-4bedB:23.12zwgB-4bedB:undetectable | 2zwgA-4bedB:10.392zwgB-4bedB:5.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZZM_A_SAMA401_1 (UNCHARACTERIZEDPROTEIN MJ0883) |
1x1n | 4-ALPHA-GLUCANOTRANSFERASE (Solanumtuberosum) | 3 / 3 | ARG A 194ASP A 88ASN A 256 | GOL A1006 (-3.7A)NoneNone | 0.60A | 2zzmA-1x1nA:undetectable | 2zzmA-1x1nA:22.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3A65_A_ACAA601_1 (6-AMINOHEXANOATE-DIMER HYDROLASE) |
4xn3 | TAIL SPIKE PROTEIN (SalmonellavirusHK620) | 5 / 12 | TYR A 393ASP A 339ASN A 471GLY A 468ILE A 426 | NAG A1006 (-3.4A)NDG A1005 (-3.0A)NDG A1005 (-3.3A)GLC A1007 (-3.2A)None | 1.47A | 3a65A-4xn3A:undetectable | 3a65A-4xn3A:20.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ARR_A_PNXA607_1 (CHITINASE A) |
4knh | NUP192P (Chaetomiumthermophilum) | 4 / 7 | TRP A 118VAL A 122THR A 227LEU A 228 | NoneNoneNoneEDO A1006 ( 4.2A) | 1.18A | 3arrA-4knhA:undetectable | 3arrA-4knhA:20.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AX7_A_SALA1336_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 8 / 8 | GLU A 802SER A 876ARG A 880PHE A 914THR A1010VAL A1011LEU A1014ALA A1079 | TEI A3006 ( 3.2A)TEI A3006 (-3.5A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)TEI A3006 (-4.8A)NoneTEI A3006 ( 3.8A) | 0.30A | 3ax7A-1n5xA:44.4 | 3ax7A-1n5xA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AX7_A_SALA1336_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 5 / 8 | SER A 876PHE A 914VAL A1011LEU A1014ALA A1078 | TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-4.8A)NoneMOS A3004 (-3.0A) | 1.12A | 3ax7A-1n5xA:44.4 | 3ax7A-1n5xA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AX7_B_SALB1336_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 9 / 9 | GLU A 802SER A 876ARG A 880PHE A 914THR A1010VAL A1011LEU A1014ALA A1078ALA A1079 | TEI A3006 ( 3.2A)TEI A3006 (-3.5A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)TEI A3006 (-4.8A)NoneMOS A3004 (-3.0A)TEI A3006 ( 3.8A) | 0.28A | 3ax7B-1n5xA:44.6 | 3ax7B-1n5xA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AX9_A_SALA1341_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 8 / 8 | GLU A 802LEU A 873SER A 876ARG A 880PHE A 914THR A1010VAL A1011ALA A1079 | TEI A3006 ( 3.2A)TEI A3006 (-4.8A)TEI A3006 (-3.5A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)TEI A3006 (-4.8A)TEI A3006 ( 3.8A) | 0.36A | 3ax9A-1n5xA:44.2 | 3ax9A-1n5xA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AX9_A_SALA1341_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 4 / 8 | SER A 876PHE A 914VAL A1011ALA A1078 | TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-4.8A)MOS A3004 (-3.0A) | 0.99A | 3ax9A-1n5xA:44.2 | 3ax9A-1n5xA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AX9_B_SALB1340_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 8 / 8 | GLU A 802LEU A 873SER A 876ARG A 880PHE A 914THR A1010ALA A1078ALA A1079 | TEI A3006 ( 3.2A)TEI A3006 (-4.8A)TEI A3006 (-3.5A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)MOS A3004 (-3.0A)TEI A3006 ( 3.8A) | 0.25A | 3ax9B-1n5xA:44.0 | 3ax9B-1n5xA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B9M_A_SALA1100_1 (SERUM ALBUMIN) |
4tkt | AT-LESS POLYKETIDESYNTHASE (Streptomycesplatensis) | 4 / 4 | LEU A3634ARG A3621LEU A3617ALA A3735 | NoneGOL A4006 (-3.0A)NoneGOL A4006 (-3.6A) | 1.18A | 3b9mA-4tktA:undetectable | 3b9mA-4tktA:20.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BC9_A_ACRA901_1 (ALPHA AMYLASE,CATALYTIC REGION) |
3oky | PLEXIN-A2 (Musmusculus) | 4 / 7 | ASP A 120SER A 122SER A 175ASP A 286 | GOL A2006 (-4.2A)GOL A2006 (-3.0A)NoneNone | 1.22A | 3bc9A-3okyA:5.4 | 3bc9A-3okyA:22.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DTU_B_CUB1022_0 (CYTOCHROME C OXIDASESUBUNIT 2) |
1vrq | SARCOSINE OXIDASEDELTA SUBUNIT (Corynebacteriumsp.U-96) | 3 / 3 | CYH D 6CYH D 63HIS D 59 | ZN D1006 (-2.4A) ZN D1006 (-2.4A) ZN D1006 (-3.2A) | 0.54A | 3dtuB-1vrqD:undetectable | 3dtuB-1vrqD:15.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DTU_B_CUB1022_0 (CYTOCHROME C OXIDASESUBUNIT 2) |
1vrq | SARCOSINE OXIDASEDELTA SUBUNIT (Corynebacteriumsp.U-96) | 3 / 3 | CYH D 9CYH D 63HIS D 59 | ZN D1006 (-2.3A) ZN D1006 (-2.4A) ZN D1006 (-3.2A) | 0.68A | 3dtuB-1vrqD:undetectable | 3dtuB-1vrqD:15.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DTU_D_CUD3_0 (CYTOCHROME C OXIDASESUBUNIT 2) |
1vrq | SARCOSINE OXIDASEDELTA SUBUNIT (Corynebacteriumsp.U-96) | 3 / 3 | CYH D 6CYH D 63HIS D 59 | ZN D1006 (-2.4A) ZN D1006 (-2.4A) ZN D1006 (-3.2A) | 0.51A | 3dtuD-1vrqD:undetectable | 3dtuD-1vrqD:15.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DTU_D_CUD3_0 (CYTOCHROME C OXIDASESUBUNIT 2) |
1vrq | SARCOSINE OXIDASEDELTA SUBUNIT (Corynebacteriumsp.U-96) | 3 / 3 | CYH D 9CYH D 63HIS D 59 | ZN D1006 (-2.3A) ZN D1006 (-2.4A) ZN D1006 (-3.2A) | 0.68A | 3dtuD-1vrqD:undetectable | 3dtuD-1vrqD:15.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FHJ_A_TRPA1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 5 / 10 | GLY A 661GLN A 665ASP A 636ILE A 635GLN A 640 | NoneALF A1005 (-3.0A) MG A1006 ( 4.0A)NoneNone | 1.36A | 3fhjA-2xzoA:undetectable | 3fhjA-2xzoA:19.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FHJ_B_TRPB1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 5 / 10 | GLY A 661GLN A 665ASP A 636ILE A 635GLN A 640 | NoneALF A1005 (-3.0A) MG A1006 ( 4.0A)NoneNone | 1.28A | 3fhjB-2xzoA:undetectable | 3fhjB-2xzoA:19.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FHJ_C_TRPC1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 5 / 10 | GLY A 661GLN A 665ASP A 636ILE A 635GLN A 640 | NoneALF A1005 (-3.0A) MG A1006 ( 4.0A)NoneNone | 1.28A | 3fhjC-2xzoA:undetectable | 3fhjC-2xzoA:19.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FHJ_E_TRPE1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 5 / 10 | GLY A 661GLN A 665ASP A 636ILE A 635GLN A 640 | NoneALF A1005 (-3.0A) MG A1006 ( 4.0A)NoneNone | 1.29A | 3fhjE-2xzoA:undetectable | 3fhjE-2xzoA:19.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FI0_A_TRPA1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 5 / 9 | GLY A 661GLN A 665ASP A 636ILE A 635GLN A 640 | NoneALF A1005 (-3.0A) MG A1006 ( 4.0A)NoneNone | 1.39A | 3fi0A-2xzoA:undetectable | 3fi0A-2xzoA:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FI0_C_TRPC1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 5 / 9 | GLY A 661GLN A 665ASP A 636ILE A 635GLN A 640 | NoneALF A1005 (-3.0A) MG A1006 ( 4.0A)NoneNone | 1.30A | 3fi0C-2xzoA:undetectable | 3fi0C-2xzoA:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FI0_K_TRPK1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 5 / 9 | GLY A 661GLN A 665ASP A 636ILE A 635GLN A 640 | NoneALF A1005 (-3.0A) MG A1006 ( 4.0A)NoneNone | 1.39A | 3fi0K-2xzoA:undetectable | 3fi0K-2xzoA:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FI0_L_TRPL1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 5 / 9 | GLY A 661GLN A 665ASP A 636ILE A 635GLN A 640 | NoneALF A1005 (-3.0A) MG A1006 ( 4.0A)NoneNone | 1.42A | 3fi0L-2xzoA:undetectable | 3fi0L-2xzoA:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FI0_M_TRPM1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 5 / 9 | GLY A 661GLN A 665ASP A 636ILE A 635GLN A 640 | NoneALF A1005 (-3.0A) MG A1006 ( 4.0A)NoneNone | 1.39A | 3fi0M-2xzoA:undetectable | 3fi0M-2xzoA:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FI0_N_TRPN1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 5 / 9 | GLY A 661GLN A 665ASP A 636ILE A 635GLN A 640 | NoneALF A1005 (-3.0A) MG A1006 ( 4.0A)NoneNone | 1.31A | 3fi0N-2xzoA:undetectable | 3fi0N-2xzoA:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FI0_O_TRPO1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 5 / 9 | GLY A 661GLN A 665ASP A 636ILE A 635GLN A 640 | NoneALF A1005 (-3.0A) MG A1006 ( 4.0A)NoneNone | 1.32A | 3fi0O-2xzoA:undetectable | 3fi0O-2xzoA:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FI0_P_TRPP1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 5 / 7 | GLY A 661GLN A 665ASP A 636ILE A 635GLN A 640 | NoneALF A1005 (-3.0A) MG A1006 ( 4.0A)NoneNone | 1.15A | 3fi0P-2xzoA:undetectable | 3fi0P-2xzoA:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FI0_R_TRPR1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 5 / 9 | GLY A 661GLN A 665ASP A 636ILE A 635GLN A 640 | NoneALF A1005 (-3.0A) MG A1006 ( 4.0A)NoneNone | 1.31A | 3fi0R-2xzoA:undetectable | 3fi0R-2xzoA:19.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FXR_A_ASCA3001_0 (LYSR TYPE REGULATOROF TSAMBCD) |
3n6u | LYSR TYPE REGULATOROF TSAMBCD (Comamonastestosteroni) | 6 / 8 | HIS A 150ARG A 199ALA A 203ARG A 211PRO A 266PRO A 268 | ACT A1006 ( 3.4A)NoneACT A1006 ( 3.8A)ACT A1007 (-3.3A)NoneACT A1006 (-4.1A) | 1.21A | 3fxrA-3n6uA:22.3 | 3fxrA-3n6uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FXR_A_ASCA3001_0 (LYSR TYPE REGULATOROF TSAMBCD) |
3n6u | LYSR TYPE REGULATOROF TSAMBCD (Comamonastestosteroni) | 6 / 8 | HIS A 150ARG A 199ALA A 203ILE A 204PRO A 266PRO A 268 | ACT A1006 ( 3.4A)NoneACT A1006 ( 3.8A)ACT A1006 ( 4.0A)NoneACT A1006 (-4.1A) | 0.94A | 3fxrA-3n6uA:22.3 | 3fxrA-3n6uA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HCO_A_CHDA3_0 (FERROCHELATASE,MITOCHONDRIAL) |
1qxo | CHORISMATE SYNTHASE (Streptococcuspneumoniae) | 4 / 4 | LEU A 371PRO A 22LEU A 374ARG A 382 | NoneEDO A3006 (-3.9A)NoneNone | 1.10A | 3hcoA-1qxoA:undetectable | 3hcoA-1qxoA:21.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JWQ_C_VIAC901_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASECATALYTIC DOMAIN,CONE CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASESUBUNIT ALPHACHIMERA) |
6bms | PALMITOYLTRANSFERASE (Daniorerio) | 4 / 7 | TYR A 59LEU A 214PHE A 207VAL A 203 | NoneLMT A1003 (-4.4A)PLM A1006 (-4.1A)PLM A1006 (-4.7A) | 1.14A | 3jwqC-6bmsA:undetectable | 3jwqC-6bmsA:12.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KKZ_A_SAMA301_0 (UNCHARACTERIZEDPROTEIN Q5LES9) |
3tej | ENTEROBACTINSYNTHASE COMPONENT F (Escherichiacoli) | 5 / 12 | GLY A1136GLY A1162LEU A1238SER A1138ALA A1144 | NoneNoneNoneUF0 A1006 ( 2.5A)None | 1.15A | 3kkzA-3tejA:2.8 | 3kkzA-3tejA:21.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KMO_B_EAAB213_1 (GLUTATHIONES-TRANSFERASE P) |
5eef | HDAC6 (Daniorerio) | 4 / 7 | VAL A 175VAL A 168ASN A 182GLY A 183 | NoneNoneEDO A2006 ( 4.1A)None | 1.07A | 3kmoB-5eefA:undetectable | 3kmoB-5eefA:20.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N62_B_ACTB860_0 (NITRIC OXIDESYNTHASE) |
4okd | ISOAMYLASE (Chlamydomonasreinhardtii) | 3 / 3 | GLY A 390TRP A 229VAL A 225 | GLC A1005 (-3.2A)GLC A1006 (-4.3A)None | 0.50A | 3n62B-4okdA:undetectable | 3n62B-4okdA:17.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N65_B_ACTB860_0 (NITRIC OXIDESYNTHASE) |
4okd | ISOAMYLASE (Chlamydomonasreinhardtii) | 3 / 3 | GLY A 390TRP A 229VAL A 225 | GLC A1005 (-3.2A)GLC A1006 (-4.3A)None | 0.53A | 3n65B-4okdA:undetectable | 3n65B-4okdA:16.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N66_B_ACTB860_0 (NITRIC OXIDESYNTHASE) |
4okd | ISOAMYLASE (Chlamydomonasreinhardtii) | 3 / 3 | GLY A 390TRP A 229VAL A 225 | GLC A1005 (-3.2A)GLC A1006 (-4.3A)None | 0.51A | 3n66B-4okdA:undetectable | 3n66B-4okdA:16.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N8X_A_NIMA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Musmusculus) | 5 / 12 | HIS A 647TYR A 309ILE A 650SER A 657LEU A 658 | NoneEDO A1006 (-4.2A)NoneNoneNone | 1.00A | 3n8xA-5hjrA:undetectable | 3n8xA-5hjrA:22.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NS1_C_PM6C1_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 6 / 6 | GLU A 802ARG A 880PHE A 914THR A1010ALA A1078ALA A1079 | TEI A3006 ( 3.2A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)MOS A3004 (-3.0A)TEI A3006 ( 3.8A) | 0.35A | 3ns1C-1n5xA:60.7 | 3ns1C-1n5xA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NS1_L_PM6L1_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 8 / 8 | GLU A 802SER A 876ARG A 880PHE A 914THR A1010LEU A1014ALA A1078ALA A1079 | TEI A3006 ( 3.2A)TEI A3006 (-3.5A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)NoneMOS A3004 (-3.0A)TEI A3006 ( 3.8A) | 0.32A | 3ns1L-1n5xA:54.6 | 3ns1L-1n5xA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3O94_B_NCAB192_0 (NICOTINAMIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 5 / 11 | PHE A1009LEU A1014TYR A1086ILE A1085SER A1082 | TEI A3006 (-4.8A)NoneNoneNoneMTE A3003 (-3.0A) | 1.50A | 3o94B-1n5xA:undetectable | 3o94B-1n5xA:10.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OU6_A_SAMA300_0 (SAM-DEPENDENTMETHYLTRANSFERASE) |
2z2z | TK-SUBTILISINPRECURSOR (Thermococcuskodakarensis) | 5 / 12 | GLY A 283GLY A 385ASP A 372LEU A 373ALA A 292 | NoneNone CA A1006 (-2.8A)NoneNone | 0.83A | 3ou6A-2z2zA:undetectable | 3ou6A-2z2zA:19.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OU6_B_SAMB300_0 (SAM-DEPENDENTMETHYLTRANSFERASE) |
2vqa | SLL1358 PROTEIN (Synechocystissp.PCC6803) | 5 / 12 | TYR A 350GLY A 269GLY A 348SER A 257HIS A 285 | ACT A1395 (-4.4A)NoneNoneNone MN A1006 ( 3.5A) | 1.13A | 3ou6B-2vqaA:undetectable | 3ou6B-2vqaA:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PMZ_E_TUBE220_1 (SOLUBLEACETYLCHOLINERECEPTOR) |
2igs | HYPOTHETICAL PROTEIN (Pseudomonasaeruginosa) | 4 / 6 | TYR A 7GLN A 8ILE A 56SER A 13 | NoneNoneNoneSO4 A2006 ( 3.8A) | 1.08A | 3pmzD-2igsA:undetectable | 3pmzD-2igsA:22.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PP1_A_ACTA590_0 (DUAL SPECIFICITYMITOGEN-ACTIVATEDPROTEIN KINASEKINASE 1) |
2ek8 | AMINOPEPTIDASE (Aneurinibacillussp.AM-1) | 4 / 5 | GLU A 383LEU A 385HIS A 363GLY A 304 | ZN A1006 (-2.1A)NoneNoneNone | 1.13A | 3pp1A-2ek8A:undetectable | 3pp1A-2ek8A:20.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PP1_A_ACTA590_0 (DUAL SPECIFICITYMITOGEN-ACTIVATEDPROTEIN KINASEKINASE 1) |
4f7z | RAP GUANINENUCLEOTIDE EXCHANGEFACTOR 4 (Musmusculus) | 4 / 5 | GLU A 576LEU A 574HIS A 774GLY A 571 | NoneNoneGOL A1006 (-4.7A)None | 0.90A | 3pp1A-4f7zA:undetectable | 3pp1A-4f7zA:14.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PRS_A_RITA1001_2 (ENDOTHIAPEPSIN) |
3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) | 5 / 12 | ASP A 32GLY A 34ASP A 215THR A 218ILE A 300 | 006 A 330 (-2.8A)006 A 330 (-3.2A)006 A 330 (-2.8A)006 A 330 (-3.5A)None | 0.30A | 3prsA-3qs1A:36.0 | 3prsA-3qs1A:25.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PWW_A_ROCA1001_1 (ENDOTHIAPEPSIN) |
3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) | 5 / 12 | ASP A 32PHE A 109ILE A 213THR A 218ILE A 300 | 006 A 330 (-2.8A)NoneNone006 A 330 (-3.5A)None | 0.75A | 3pwwA-3qs1A:35.9 | 3pwwA-3qs1A:25.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PWW_A_ROCA1001_2 (ENDOTHIAPEPSIN) |
3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) | 4 / 8 | GLY A 34SER A 35TYR A 75ASP A 215 | 006 A 330 (-3.2A)006 A 330 (-4.5A)006 A 330 (-4.3A)006 A 330 (-2.8A) | 0.45A | 3pwwA-3qs1A:35.9 | 3pwwA-3qs1A:25.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q70_A_RITA2001_1 (CANDIDAPEPSIN-2) |
3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) | 6 / 12 | ILE A 30ASP A 32GLY A 34ASP A 215THR A 218ILE A 300 | 006 A 330 ( 4.4A)006 A 330 (-2.8A)006 A 330 (-3.2A)006 A 330 (-2.8A)006 A 330 (-3.5A)None | 0.32A | 3q70A-3qs1A:9.9 | 3q70A-3qs1A:28.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QEO_B_LLTB261_1 (DEOXYCYTIDINE KINASE) |
6bms | PALMITOYLTRANSFERASE (Daniorerio) | 4 / 7 | VAL A 19TYR A 59PHE A 207LEU A 211 | PLM A1006 ( 4.9A)NonePLM A1006 (-4.1A)None | 0.99A | 3qeoB-6bmsA:undetectable | 3qeoB-6bmsA:13.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QPK_A_CUA602_0 (LACCASE-1) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | HIS B2141HIS B2150HIS B2122 | CUO B9006 (-3.1A)CUO B9006 (-3.3A)CUO B9006 (-3.2A) | 0.35A | 3qpkA-4bedB:3.8 | 3qpkA-4bedB:15.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QPK_B_CUB602_0 (LACCASE-1) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | HIS B2141HIS B2150HIS B2122 | CUO B9006 (-3.1A)CUO B9006 (-3.3A)CUO B9006 (-3.2A) | 0.33A | 3qpkB-4bedB:3.4 | 3qpkB-4bedB:15.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RC0_A_SAMA484_0 (N-LYSINEMETHYLTRANSFERASESETD6) |
4yu5 | IMMUNE INHIBITOR A,METALLOPROTEASE (Bacilluscereus) | 5 / 11 | VAL A 795ALA A 794GLY A 785ALA A 152LEU A 648 | NoneKH2 A1006 (-3.7A)NoneNoneNone | 1.18A | 3rc0A-4yu5A:undetectable | 3rc0A-4yu5A:19.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RC0_B_SAMB480_0 (N-LYSINEMETHYLTRANSFERASESETD6) |
4yu5 | IMMUNE INHIBITOR A,METALLOPROTEASE (Bacilluscereus) | 5 / 12 | VAL A 795ALA A 794GLY A 785ALA A 152LEU A 648 | NoneKH2 A1006 (-3.7A)NoneNoneNone | 1.18A | 3rc0B-4yu5A:undetectable | 3rc0B-4yu5A:19.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SFU_A_RBVA601_1 (RNA POLYMERASE) |
5jjr | GENOME POLYPROTEIN (Denguevirus) | 5 / 9 | ASP A 538ASN A 609GLY A 662ASP A 663ASP A 664 | NoneNoneNoneNone MG A1006 (-2.7A) | 0.89A | 3sfuA-5jjrA:20.3 | 3sfuA-5jjrA:20.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SFU_A_RBVA601_1 (RNA POLYMERASE) |
5jjr | GENOME POLYPROTEIN (Denguevirus) | 5 / 9 | ASP A 538SER A 600GLY A 662ASP A 663ASP A 664 | NoneNoneNoneNone MG A1006 (-2.7A) | 1.15A | 3sfuA-5jjrA:20.3 | 3sfuA-5jjrA:20.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SI7_B_ACTB4_0 (CYSTIC FIBROSISTRANSMEMBRANECONDUCTANCEREGULATOR) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 3 / 3 | GLY A 495GLY A 497THR A 499 | ADP A1004 ( 3.2A)ADP A1004 (-3.2A) MG A1006 ( 3.3A) | 0.46A | 3si7B-2xzoA:undetectable | 3si7B-2xzoA:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SO9_A_017A100_1 (HIV-1 PROTEASE) |
2r6f | EXCINUCLEASE ABCSUBUNIT A (Geobacillusstearothermophilus) | 5 / 8 | ASN A 696GLY A 820GLY A 743ILE A 744THR A 692 | NoneNone ZN A1006 ( 4.4A)NoneNone | 1.49A | 3so9A-2r6fA:undetectable | 3so9A-2r6fA:7.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T3S_D_9PLD1_1 (CYTOCHROME P450 2A13) |
1n2m | PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE (Methanocaldococcusjannaschii) | 4 / 8 | PHE A 34ALA A 41ALA A 159THR A 75 | MRD A7006 ( 3.9A)NoneNoneNone | 0.94A | 3t3sD-1n2mA:undetectable | 3t3sD-1n2mA:15.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TM4_A_SAMA401_0 (TRNA (GUANINEN2-)-METHYLTRANSFERASE TRM14) |
1g5b | SERINE/THREONINEPROTEIN PHOSPHATASE (EscherichiavirusLambda) | 5 / 12 | ALA A 205GLY A 23HIS A 22ASN A 27LEU A 44 | NoneNone MN A1006 (-3.4A)NoneNone | 1.12A | 3tm4A-1g5bA:undetectable | 3tm4A-1g5bA:20.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TM4_B_SAMB401_0 (TRNA (GUANINEN2-)-METHYLTRANSFERASE TRM14) |
1g5b | SERINE/THREONINEPROTEIN PHOSPHATASE (EscherichiavirusLambda) | 5 / 12 | ALA A 205GLY A 23HIS A 22ASN A 27LEU A 44 | NoneNone MN A1006 (-3.4A)NoneNone | 1.17A | 3tm4B-1g5bA:undetectable | 3tm4B-1g5bA:20.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TNE_A_RITA401_1 (SECRETED ASPARTICPROTEASE) |
3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) | 5 / 12 | ILE A 30ASP A 32GLY A 34ASP A 215ILE A 300 | 006 A 330 ( 4.4A)006 A 330 (-2.8A)006 A 330 (-3.2A)006 A 330 (-2.8A)None | 0.37A | 3tneA-3qs1A:34.9 | 3tneA-3qs1A:28.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TNE_A_RITA401_1 (SECRETED ASPARTICPROTEASE) |
3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) | 5 / 12 | ILE A 213ASP A 215GLY A 217ASP A 32ILE A 120 | None006 A 330 (-2.8A)006 A 330 (-3.4A)006 A 330 (-2.8A)006 A 330 ( 4.8A) | 0.78A | 3tneA-3qs1A:34.9 | 3tneA-3qs1A:28.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TNE_B_RITB401_1 (SECRETED ASPARTICPROTEASE) |
3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) | 5 / 12 | ILE A 30ASP A 32GLY A 34ASP A 215ILE A 300 | 006 A 330 ( 4.4A)006 A 330 (-2.8A)006 A 330 (-3.2A)006 A 330 (-2.8A)None | 0.36A | 3tneB-3qs1A:35.0 | 3tneB-3qs1A:28.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TNE_B_RITB401_1 (SECRETED ASPARTICPROTEASE) |
3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) | 5 / 12 | ILE A 213ASP A 215GLY A 217ASP A 32ILE A 120 | None006 A 330 (-2.8A)006 A 330 (-3.4A)006 A 330 (-2.8A)006 A 330 ( 4.8A) | 0.81A | 3tneB-3qs1A:35.0 | 3tneB-3qs1A:28.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TNE_B_RITB401_2 (SECRETED ASPARTICPROTEASE) |
3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) | 4 / 7 | SER A 35TYR A 75ILE A 120THR A 218 | 006 A 330 (-4.5A)006 A 330 (-4.3A)006 A 330 ( 4.8A)006 A 330 (-3.5A) | 0.72A | 3tneB-3qs1A:35.0 | 3tneB-3qs1A:28.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UNA_A_SALA1340_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 9 / 9 | GLU A 802LEU A 873SER A 876ARG A 880PHE A 914THR A1010VAL A1011LEU A1014ALA A1079 | TEI A3006 ( 3.2A)TEI A3006 (-4.8A)TEI A3006 (-3.5A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)TEI A3006 (-4.8A)NoneTEI A3006 ( 3.8A) | 0.28A | 3unaA-1n5xA:49.5 | 3unaA-1n5xA:99.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UNA_A_SALA1340_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 5 / 9 | SER A 876PHE A 914VAL A1011LEU A1014ALA A1078 | TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-4.8A)NoneMOS A3004 (-3.0A) | 1.20A | 3unaA-1n5xA:49.5 | 3unaA-1n5xA:99.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UNA_B_SALB1340_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 9 / 9 | GLU A 802LEU A 873SER A 876ARG A 880PHE A 914THR A1010VAL A1011LEU A1014ALA A1079 | TEI A3006 ( 3.2A)TEI A3006 (-4.8A)TEI A3006 (-3.5A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)TEI A3006 (-4.8A)NoneTEI A3006 ( 3.8A) | 0.27A | 3unaB-1n5xA:46.7 | 3unaB-1n5xA:99.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UNA_B_SALB1340_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 5 / 9 | SER A 876PHE A 914VAL A1011LEU A1014ALA A1078 | TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-4.8A)NoneMOS A3004 (-3.0A) | 1.18A | 3unaB-1n5xA:46.7 | 3unaB-1n5xA:99.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UNC_A_SALA1338_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 9 / 9 | GLU A 802LEU A 873SER A 876ARG A 880PHE A 914THR A1010VAL A1011LEU A1014ALA A1079 | TEI A3006 ( 3.2A)TEI A3006 (-4.8A)TEI A3006 (-3.5A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)TEI A3006 (-4.8A)NoneTEI A3006 ( 3.8A) | 0.29A | 3uncA-1n5xA:48.3 | 3uncA-1n5xA:99.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UNC_A_SALA1338_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 5 / 9 | SER A 876PHE A 914VAL A1011LEU A1014ALA A1078 | TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-4.8A)NoneMOS A3004 (-3.0A) | 1.16A | 3uncA-1n5xA:48.3 | 3uncA-1n5xA:99.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UNC_B_SALB1338_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 9 / 9 | GLU A 802LEU A 873SER A 876ARG A 880PHE A 914THR A1010VAL A1011LEU A1014ALA A1079 | TEI A3006 ( 3.2A)TEI A3006 (-4.8A)TEI A3006 (-3.5A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)TEI A3006 (-4.8A)NoneTEI A3006 ( 3.8A) | 0.29A | 3uncB-1n5xA:46.8 | 3uncB-1n5xA:99.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UNC_B_SALB1338_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 5 / 9 | SER A 876PHE A 914VAL A1011LEU A1014ALA A1078 | TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-4.8A)NoneMOS A3004 (-3.0A) | 1.15A | 3uncB-1n5xA:46.8 | 3uncB-1n5xA:99.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UNI_A_SALA1344_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 7 / 7 | GLU A 802ARG A 880PHE A 914THR A1010VAL A1011LEU A1014ALA A1079 | TEI A3006 ( 3.2A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)TEI A3006 (-4.8A)NoneTEI A3006 ( 3.8A) | 0.29A | 3uniA-1n5xA:46.7 | 3uniA-1n5xA:99.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UNI_B_SALB1345_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 8 / 8 | GLU A 802LEU A 873ARG A 880PHE A 914THR A1010VAL A1011LEU A1014ALA A1079 | TEI A3006 ( 3.2A)TEI A3006 (-4.8A)TEI A3006 (-3.5A)TEI A3006 (-3.6A)TEI A3006 (-2.8A)TEI A3006 (-4.8A)NoneTEI A3006 ( 3.8A) | 0.28A | 3uniB-1n5xA:46.7 | 3uniB-1n5xA:99.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UUD_B_ESTB600_1 (ESTROGEN RECEPTOR) |
3umm | PHOSPHORIBOSYLFORMYLGLYCINAMIDINESYNTHASE (Salmonellaenterica) | 5 / 10 | ALA A 719GLU A 718LEU A 714ARG A 700LEU A 770 | None MG A2006 ( 2.7A)NoneNoneNone | 1.43A | 3uudB-3ummA:undetectable | 3uudB-3ummA:12.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V3N_B_MIYB2001_1 (TETX2 PROTEIN) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 4 / 8 | GLN A 918PHE A 914GLY A 915GLY A 800 | NoneTEI A3006 (-3.6A)NoneNone | 0.83A | 3v3nB-1n5xA:undetectable | 3v3nB-1n5xA:14.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V3N_B_MIYB2001_1 (TETX2 PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 4 / 8 | GLN A 918PHE A 914GLY A 915GLY A 800 | BCT A3006 (-3.0A)URC A3007 ( 3.4A)BCT A3006 (-3.9A)None | 0.75A | 3v3nB-4yswA:undetectable | 3v3nB-4yswA:13.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V3N_C_MIYC2001_1 (TETX2 PROTEIN) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 4 / 8 | GLN A 918PHE A 914GLY A 915GLY A 800 | NoneTEI A3006 (-3.6A)NoneNone | 0.82A | 3v3nC-1n5xA:undetectable | 3v3nC-1n5xA:14.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V3N_C_MIYC2001_1 (TETX2 PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 4 / 8 | GLN A 918PHE A 914GLY A 915GLY A 800 | BCT A3006 (-3.0A)URC A3007 ( 3.4A)BCT A3006 (-3.9A)None | 0.74A | 3v3nC-4yswA:undetectable | 3v3nC-4yswA:13.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W6H_A_AZMA303_1 (CARBONIC ANHYDRASE 1) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 8 | HIS B2264HIS B2260HIS B2290HIS B2150 | CUO B9006 (-3.2A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.3A) | 1.02A | 3w6hA-4bedB:undetectable | 3w6hA-4bedB:9.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A7B_A_HAEA1273_1 (COLLAGENASE 3) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 6 | HIS B2290HIS B2141HIS B2150HIS B2122 | NoneCUO B9006 (-3.1A)CUO B9006 (-3.3A)CUO B9006 (-3.2A) | 0.91A | 4a7bA-4bedB:undetectable | 4a7bA-4bedB:6.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A7B_B_HAEB1270_1 (COLLAGENASE 3) |
2vqa | SLL1358 PROTEIN (Synechocystissp.PCC6803) | 4 / 5 | LEU A 253HIS A 329GLU A 290HIS A 285 | ACT A1395 (-4.8A) MN A1006 (-3.5A) MN A1006 ( 2.3A) MN A1006 ( 3.5A) | 1.31A | 4a7bB-2vqaA:undetectable | 4a7bB-2vqaA:18.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BUP_B_SAMB500_1 (HISTONE-LYSINEN-METHYLTRANSFERASESUV420H1) |
3aux | DNA DOUBLE-STRANDBREAK REPAIR RAD50ATPASE (Methanocaldococcusjannaschii) | 3 / 3 | HIS A 979GLU A 947ASN A 34 | NoneNoneADP A1006 ( 4.8A) | 0.97A | 4bupB-3auxA:undetectable | 4bupB-3auxA:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DTA_A_ADNA401_1 (APH(2'')-ID) |
2z2x | TK-SUBTILISIN (Thermococcuskodakarensis) | 5 / 10 | ALA A 227ILE A 204ILE A 200LEU A 114ILE A 231 | CA A1006 (-4.9A)NoneNoneNoneNone | 1.25A | 4dtaA-2z2xA:undetectable | 4dtaA-2z2xA:20.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E0F_A_RBFA301_1 (RIBOFLAVIN SYNTHASESUBUNIT ALPHA) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 5 / 11 | SER A 235VAL A 231THR A 236HIS A 174VAL A 173 | NoneNoneNone ZN A1006 (-3.2A)None | 1.03A | 4e0fA-2z00A:undetectable | 4e0fA-2z00A:19.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E7C_A_ACTA504_0 (UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE) |
4zmh | UNCHARACTERIZEDPROTEIN (Saccharophagusdegradans) | 3 / 3 | ARG A 919TRP A 405GLY A 434 | NoneNoneGOL A1006 ( 2.9A) | 0.90A | 4e7cA-4zmhA:undetectable | 4e7cA-4zmhA:18.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EK1_A_CAMA502_0 (CAMPHOR5-MONOOXYGENASE) |
4pd4 | CYTOCHROME B (Saccharomycescerevisiae) | 4 / 6 | PHE C 329LEU C 302VAL C 301VAL C 367 | 3PH C4006 ( 4.9A)NoneNoneNone | 1.12A | 4ek1A-4pd4C:undetectable | 4ek1A-4pd4C:20.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4F93_B_SANB3004_1 (U5 SMALL NUCLEARRIBONUCLEOPROTEIN200 KDA HELICASE) |
5iu9 | PROTOCADHERIN-19ISOFORM 1 (Daniorerio) | 4 / 8 | GLU A 176GLU A 249ASN A 209GLY A 299 | CA A1005 ( 2.4A)None CA A1006 (-3.4A)None | 0.95A | 4f93B-5iu9A:undetectable | 4f93B-5iu9A:12.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEU_F_KANF301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
1ux6 | THROMBOSPONDIN-1 (Homosapiens) | 4 / 8 | ASP A 874ASP A 870ASP A 890ASN A 882 | None CA A2007 ( 2.8A) CA A2005 ( 2.2A) CA A2006 (-2.8A) | 1.19A | 4feuF-1ux6A:undetectable | 4feuF-1ux6A:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEV_D_KAND301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
1ux6 | THROMBOSPONDIN-1 (Homosapiens) | 4 / 7 | ASP A 874ASP A 870ASP A 890ASN A 882 | None CA A2007 ( 2.8A) CA A2005 ( 2.2A) CA A2006 (-2.8A) | 1.17A | 4fevD-1ux6A:undetectable | 4fevD-1ux6A:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEV_F_KANF301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
1ux6 | THROMBOSPONDIN-1 (Homosapiens) | 4 / 7 | ASP A 874ASP A 870ASP A 890ASN A 882 | None CA A2007 ( 2.8A) CA A2005 ( 2.2A) CA A2006 (-2.8A) | 1.18A | 4fevF-1ux6A:undetectable | 4fevF-1ux6A:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEW_B_KANB301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
1ux6 | THROMBOSPONDIN-1 (Homosapiens) | 4 / 7 | ASP A 874ASP A 870ASP A 890ASN A 882 | None CA A2007 ( 2.8A) CA A2005 ( 2.2A) CA A2006 (-2.8A) | 1.21A | 4fewB-1ux6A:undetectable | 4fewB-1ux6A:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEW_D_KAND301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
1ux6 | THROMBOSPONDIN-1 (Homosapiens) | 4 / 8 | ASP A 874ASP A 870ASP A 890ASN A 882 | None CA A2007 ( 2.8A) CA A2005 ( 2.2A) CA A2006 (-2.8A) | 1.16A | 4fewD-1ux6A:undetectable | 4fewD-1ux6A:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEW_D_KAND301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
3ob8 | BETA-GALACTOSIDASE (Kluyveromyceslactis) | 4 / 8 | ASP A 187ASP A 623CYH A1001GLU A 583 | NA A3006 ( 3.1A) NA A3006 ( 3.0A)GAL A2001 ( 4.4A)None | 1.22A | 4fewD-3ob8A:undetectable | 4fewD-3ob8A:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEW_F_KANF301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
1ux6 | THROMBOSPONDIN-1 (Homosapiens) | 4 / 8 | ASP A 874ASP A 870ASP A 890ASN A 882 | None CA A2007 ( 2.8A) CA A2005 ( 2.2A) CA A2006 (-2.8A) | 1.19A | 4fewF-1ux6A:undetectable | 4fewF-1ux6A:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEW_F_KANF301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
3ob8 | BETA-GALACTOSIDASE (Kluyveromyceslactis) | 4 / 8 | ASP A 187ASP A 623CYH A1001GLU A 583 | NA A3006 ( 3.1A) NA A3006 ( 3.0A)GAL A2001 ( 4.4A)None | 1.21A | 4fewF-3ob8A:undetectable | 4fewF-3ob8A:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEX_B_KANB301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
1ux6 | THROMBOSPONDIN-1 (Homosapiens) | 4 / 7 | ASP A 874ASP A 870ASP A 890ASN A 882 | None CA A2007 ( 2.8A) CA A2005 ( 2.2A) CA A2006 (-2.8A) | 1.19A | 4fexB-1ux6A:0.5 | 4fexB-1ux6A:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FGL_C_CLQC303_1 (RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE[QUINONE]) |
1c30 | CARBAMOYL PHOSPHATESYNTHETASE: LARGESUBUNIT (Escherichiacoli) | 4 / 8 | GLY A 908VAL A 787HIS A 788PHE A 367 | None K A4009 ( 4.4A)ADP A4006 (-4.2A)None | 0.97A | 4fglD-1c30A:3.4 | 4fglD-1c30A:13.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKH_B_KANB301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
1ux6 | THROMBOSPONDIN-1 (Homosapiens) | 4 / 8 | ASP A 874ASP A 870ASP A 890ASN A 882 | None CA A2007 ( 2.8A) CA A2005 ( 2.2A) CA A2006 (-2.8A) | 1.15A | 4gkhB-1ux6A:undetectable | 4gkhB-1ux6A:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKH_G_KANG301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
1ux6 | THROMBOSPONDIN-1 (Homosapiens) | 4 / 7 | ASP A 874ASP A 870ASP A 890ASN A 882 | None CA A2007 ( 2.8A) CA A2005 ( 2.2A) CA A2006 (-2.8A) | 1.19A | 4gkhG-1ux6A:undetectable | 4gkhG-1ux6A:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKH_J_KANJ301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
1ux6 | THROMBOSPONDIN-1 (Homosapiens) | 4 / 6 | ASP A 874ASP A 870ASP A 890ASN A 882 | None CA A2007 ( 2.8A) CA A2005 ( 2.2A) CA A2006 (-2.8A) | 1.22A | 4gkhJ-1ux6A:undetectable | 4gkhJ-1ux6A:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKI_A_KANA301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
1ux6 | THROMBOSPONDIN-1 (Homosapiens) | 4 / 8 | ASP A 874ASP A 870ASP A 890ASN A 882 | None CA A2007 ( 2.8A) CA A2005 ( 2.2A) CA A2006 (-2.8A) | 1.17A | 4gkiA-1ux6A:undetectable | 4gkiA-1ux6A:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKI_C_KANC301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
1ux6 | THROMBOSPONDIN-1 (Homosapiens) | 4 / 8 | ASP A 874ASP A 870ASP A 890ASN A 882 | None CA A2007 ( 2.8A) CA A2005 ( 2.2A) CA A2006 (-2.8A) | 1.20A | 4gkiC-1ux6A:undetectable | 4gkiC-1ux6A:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GRQ_C_AVLC203_1 (MACROPHAGE MIGRATIONINHIBITORY FACTOR) |
4pd4 | CYTOCHROME B (Saccharomycescerevisiae) | 4 / 7 | PHE C 329TYR C 359PRO C 277PHE C 278 | 3PH C4006 ( 4.9A)NoneNoneAOQ C4003 ( 4.6A) | 1.35A | 4grqA-4pd4C:undetectable4grqC-4pd4C:undetectable | 4grqA-4pd4C:13.814grqC-4pd4C:13.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4H9M_A_HAEA929_1 (UREASE) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 4 / 5 | HIS A 55HIS A 174HIS A 233ASP A 306 | ZN A1004 (-3.2A) ZN A1006 (-3.2A) ZN A1006 (-3.4A) ZN A1004 (-2.9A) | 0.62A | 4h9mA-2z00A:23.4 | 4h9mA-2z00A:20.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HVR_A_SALA203_1 (3-HYDROXYANTHRANILATE 3,4-DIOXYGENASE) |
5wmm | NRPS (Micromonosporasp.ML1) | 4 / 7 | ASP A 200GLU A 277HIS A 201VAL A 303 | CA A1006 (-3.4A) CA A1006 (-3.3A)NoneNone | 0.97A | 4hvrA-5wmmA:undetectable | 4hvrA-5wmmA:26.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JEC_B_478B401_3 (HIV-1 PROTEASE) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 3 / 3 | ASP A 147LEU A 143VAL A 253 | ZN A1006 ( 2.5A)NoneNone | 0.69A | 4jecB-2z00A:undetectable | 4jecB-2z00A:12.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K50_A_ACTA505_0 (RNA POLYMERASE3D-POL) |
5wg6 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,POLYCOMBPROTEIN SUZ12(E.C.2.1.1.43)CHIMERA (Homosapiens) | 3 / 3 | CYH A 601ASN A 567LYS A 563 | ZN A9006 (-2.2A)NoneNone | 1.26A | 4k50A-5wg6A:2.6 | 4k50A-5wg6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KLA_A_CHDA502_0 (FERROCHELATASE,MITOCHONDRIAL) |
2no5 | (S)-2-HALOACIDDEHALOGENASE IVA (Burkholderiacepacia) | 4 / 8 | LEU A 216LEU A 219LEU A 223LYS A 12 | SO4 A1006 ( 3.4A)NoneNoneASL A 11 ( 3.3A) | 0.82A | 4klaA-2no5A:2.8 | 4klaA-2no5A:22.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KOE_F_TR6F101_1 (DNA TOPOISOMERASE 4SUBUNIT ADNA TOPOISOMERASE 4SUBUNIT BE-SITE DNA2) |
5iu9 | PROTOCADHERIN-19ISOFORM 1 (Daniorerio) | 4 / 6 | SER A 116GLY A 248ASP A 241GLY A 299 | None CA A1006 ( 4.4A) CA A1006 (-2.1A)None | 0.99A | 4koeA-5iu9A:undetectable4koeB-5iu9A:undetectable4koeC-5iu9A:undetectable | 4koeA-5iu9A:25.004koeB-5iu9A:25.004koeC-5iu9A:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MMF_B_29QB603_1 (TRANSPORTER) |
2e3j | EPOXIDE HYDROLASEEPHB (Mycobacteriumtuberculosis) | 5 / 9 | ASP A 20VAL A 30GLY A 52SER A 21GLY A 27 | NoneNoneNoneNoneACT A2006 ( 4.8A) | 1.40A | 4mmfB-2e3jA:undetectable | 4mmfB-2e3jA:23.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4P6S_A_DAHA305_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 6 / 7 | HIS B2122HIS B2141HIS B2260ASN B2261HIS B2264ALA B2281 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A)None | 0.78A | 4p6sA-4bedB:21.9 | 4p6sA-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4P6S_A_DAHA305_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 6 / 7 | HIS B2122HIS B2150HIS B2260ASN B2261HIS B2264ALA B2281 | CUO B9006 (-3.2A)CUO B9006 (-3.3A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A)None | 1.49A | 4p6sA-4bedB:21.9 | 4p6sA-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4P6S_A_DAHA305_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 7 | HIS B2264HIS B2291HIS B2122ALA B2281 | CUO B9006 (-3.2A)CUO B9006 (-3.5A)CUO B9006 (-3.2A)None | 0.85A | 4p6sA-4bedB:21.9 | 4p6sA-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4P6S_B_DAHB305_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 7 | HIS B2122HIS B2141HIS B2260ASN B2261HIS B2264 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A) | 0.85A | 4p6sB-4bedB:10.1 | 4p6sB-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PAE_A_NIZA804_1 (CATALASE-PEROXIDASE) |
1g8k | ARSENITE OXIDASE (Alcaligenesfaecalis) | 4 / 6 | ASP B 101TYR B 56LEU B 102THR B 83 | NoneNoneNoneFES B5006 (-3.8A) | 1.29A | 4paeA-1g8kB:undetectable | 4paeA-1g8kB:10.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Q5M_A_ROCA1101_3 (PROTEASE) |
3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) | 3 / 3 | ASP A 215ASP A 32ASN A 37 | 006 A 330 (-2.8A)006 A 330 (-2.8A)None | 0.71A | 4q5mA-3qs1A:10.0 | 4q5mA-3qs1A:22.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QOI_A_ML1A303_1 (RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE[QUINONE]) |
2cdp | BETA-AGARASE 1 (Saccharophagusdegradans) | 4 / 8 | TYR A 30PHE A 100GLY A 68ASN A 130 | AAL A1006 ( 4.8A)NoneNoneAAL A1006 (-3.4A) | 0.97A | 4qoiA-2cdpA:undetectable4qoiB-2cdpA:undetectable | 4qoiA-2cdpA:20.874qoiB-2cdpA:20.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVY_B_BO2B201_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-1) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 5 / 11 | HIS A 233THR A 305THR A 258ARG A 59ALA A 308 | ZN A1006 (-3.4A)NoneNoneNoneNone | 1.49A | 4qvyV-2z00A:undetectable4qvyb-2z00A:undetectable | 4qvyV-2z00A:19.314qvyb-2z00A:17.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVY_N_BO2N201_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-1) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 5 / 11 | HIS A 233THR A 305THR A 258ARG A 59ALA A 308 | ZN A1006 (-3.4A)NoneNoneNoneNone | 1.49A | 4qvyH-2z00A:undetectable4qvyN-2z00A:undetectable | 4qvyH-2z00A:19.314qvyN-2z00A:17.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R29_B_SAMB301_0 (UNCHARACTERIZEDPROTEIN) |
1n5x | XANTHINEDEHYDROGENASE (Bostaurus) | 5 / 12 | ALA A1258GLY A1006GLU A 802ALA A 910GLY A 913 | NoneNoneTEI A3006 ( 3.2A)MOS A3004 ( 4.7A)None | 1.08A | 4r29B-1n5xA:0.0 | 4r29B-1n5xA:10.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RMJ_A_NCAA402_0 (NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-2) |
3oky | PLEXIN-A2 (Musmusculus) | 4 / 7 | ILE A 184LEU A 213LEU A 127ILE A 172 | NoneNoneNoneGOL A2006 (-3.9A) | 0.86A | 4rmjA-3okyA:undetectable | 4rmjA-3okyA:17.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RTM_A_SAMA301_0 (DNA ADENINEMETHYLASE) |
2cdp | BETA-AGARASE 1 (Saccharophagusdegradans) | 5 / 12 | GLY A 72GLY A 121ALA A 122SER A 28TYR A 40 | NoneNoneNoneNoneAAL A1006 ( 3.8A) | 1.00A | 4rtmA-2cdpA:undetectable | 4rtmA-2cdpA:23.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UBP_C_HAEC800_1 (PROTEIN (UREASE(CHAIN C))) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 5 / 6 | HIS A 55HIS A 57HIS A 174HIS A 233ASP A 306 | ZN A1004 (-3.2A) ZN A1004 (-3.4A) ZN A1006 (-3.2A) ZN A1006 (-3.4A) ZN A1004 (-2.9A) | 0.51A | 4ubpC-2z00A:22.5 | 4ubpC-2z00A:23.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UYM_A_VORA590_1 (14-ALPHA STEROLDEMETHYLASE) |
4aay | AROB (Rhizobiumsp.NT-26) | 4 / 7 | ALA B 141SER B 126LEU B 145PHE B 128 | NoneFES B2006 (-2.9A)NoneNone | 1.07A | 4uymA-4aayB:undetectable | 4uymA-4aayB:16.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WNU_A_QDNA602_1 (CYTOCHROME P450 2D6) |
6ffh | METABOTROPICGLUTAMATE RECEPTOR5,ENDOLYSIN (EscherichiavirusT4;Homosapiens) | 5 / 11 | GLY A 628LEU A 630LEU A1814ALA A 593PHE A 633 | D7W A4006 (-3.4A)YCM A 634 ( 4.2A)NoneNoneOLA A4004 (-4.8A) | 1.17A | 4wnuA-6ffhA:undetectable | 4wnuA-6ffhA:9.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Z53_F_TR6F101_1 (DNA TOPOISOMERASE 4SUBUNIT B,DNATOPOISOMERASE 4SUBUNIT AE-SITE DNA) |
5iu9 | PROTOCADHERIN-19ISOFORM 1 (Daniorerio) | 4 / 6 | GLY A 248ASP A 241GLY A 299SER A 116 | CA A1006 ( 4.4A) CA A1006 (-2.1A)NoneNone | 0.99A | 4z53A-5iu9A:undetectable4z53B-5iu9A:undetectable | 4z53A-5iu9A:21.324z53B-5iu9A:21.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZBQ_A_ACTA605_0 (SERUM ALBUMIN) |
3azq | AMINOPEPTIDASE (Streptomycesmorookaense) | 4 / 6 | TYR A 471HIS A 405GLY A 314ARG A 437 | NoneNoneSO4 A1006 ( 3.8A)SO4 A1006 (-3.7A) | 1.31A | 4zbqA-3azqA:undetectable | 4zbqA-3azqA:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5A5Z_C_WJZC304_0 (BETA-LACTAMASE NDM-1) |
5wfc | HISTONE-LYSINE-N-METHYLTRANSFERASE EZH2,POLYCOMB PROTEINSUZ12 CHIMERA (Chaetomiumthermophilum) | 4 / 7 | HIS B 687CYH B 685GLY B 696ASN B 695 | ZN B8004 (-3.2A) ZN B8006 ( 2.3A)NoneNone | 1.21A | 5a5zC-5wfcB:undetectable | 5a5zC-5wfcB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BXN_B_BO2B201_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-1) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 5 / 11 | HIS A 233THR A 305THR A 258ARG A 59ALA A 308 | ZN A1006 (-3.4A)NoneNoneNoneNone | 1.48A | 5bxnV-2z00A:undetectable5bxnb-2z00A:undetectable | 5bxnV-2z00A:19.315bxnb-2z00A:17.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BXN_N_BO2N201_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-1) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 5 / 11 | HIS A 233THR A 305THR A 258ARG A 59ALA A 308 | ZN A1006 (-3.4A)NoneNoneNoneNone | 1.47A | 5bxnH-2z00A:undetectable5bxnN-2z00A:undetectable | 5bxnH-2z00A:19.315bxnN-2z00A:17.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CLT_A_ACRA1000_1 (1,4-ALPHA-GLUCAN-BRANCHING ENZYME) |
5clw | 1,4-ALPHA-GLUCAN-BRANCHING ENZYME (Homosapiens) | 10 / 10 | ASN A 62GLU A 63TRP A 91PRO A 93TYR A 119GLY A 120LYS A 121TRP A 332GLU A 333ARG A 336 | GLC A1004 ( 3.2A)GLC A1004 ( 3.4A)GLC A1006 ( 3.8A)GLC A1007 ( 4.0A)GLC A1005 ( 3.8A)GLC A1007 ( 3.7A)GLC A1005 ( 2.9A)GLC A1005 ( 4.8A)GLC A1005 ( 3.5A)GLC A1005 ( 4.3A) | 0.32A | 5cltA-5clwA:64.8 | 5cltA-5clwA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CLT_B_ACRB1000_1 (1,4-ALPHA-GLUCAN-BRANCHING ENZYME) |
5clw | 1,4-ALPHA-GLUCAN-BRANCHING ENZYME (Homosapiens) | 10 / 10 | ASN A 62GLU A 63TRP A 91PRO A 93TYR A 119GLY A 120LYS A 121TRP A 332GLU A 333ARG A 336 | GLC A1004 ( 3.2A)GLC A1004 ( 3.4A)GLC A1006 ( 3.8A)GLC A1007 ( 4.0A)GLC A1005 ( 3.8A)GLC A1007 ( 3.7A)GLC A1005 ( 2.9A)GLC A1005 ( 4.8A)GLC A1005 ( 3.5A)GLC A1005 ( 4.3A) | 0.36A | 5cltB-5clwA:67.0 | 5cltB-5clwA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CLT_C_ACRC1000_1 (1,4-ALPHA-GLUCAN-BRANCHING ENZYME) |
5clw | 1,4-ALPHA-GLUCAN-BRANCHING ENZYME (Homosapiens) | 10 / 10 | ASN A 62GLU A 63TRP A 91PRO A 93TYR A 119GLY A 120LYS A 121TRP A 332GLU A 333ARG A 336 | GLC A1004 ( 3.2A)GLC A1004 ( 3.4A)GLC A1006 ( 3.8A)GLC A1007 ( 4.0A)GLC A1005 ( 3.8A)GLC A1007 ( 3.7A)GLC A1005 ( 2.9A)GLC A1005 ( 4.8A)GLC A1005 ( 3.5A)GLC A1005 ( 4.3A) | 0.29A | 5cltC-5clwA:66.1 | 5cltC-5clwA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DXE_B_ESTB1000_1 (ESTROGEN RECEPTOR) |
3umm | PHOSPHORIBOSYLFORMYLGLYCINAMIDINESYNTHASE (Salmonellaenterica) | 5 / 10 | ALA A 719GLU A 718LEU A 714ARG A 700LEU A 770 | None MG A2006 ( 2.7A)NoneNoneNone | 1.45A | 5dxeB-3ummA:undetectable | 5dxeB-3ummA:12.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_O_BEZO801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
4aay | AROB (Rhizobiumsp.NT-26) | 4 / 6 | PHE B 108SER B 126PRO B 122LEU B 110 | NoneFES B2006 (-2.9A)NoneNone | 1.45A | 5dzka-4aayB:undetectable5dzko-4aayB:undetectable | 5dzka-4aayB:19.825dzko-4aayB:2.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E5J_A_017A201_3 (PROTEASE) |
2vc2 | INTEGRIN ALPHA-IIB (Homosapiens) | 3 / 3 | ASP A 367VAL A 391LEU A 3 | CA A2006 (-2.9A)NoneNone | 0.68A | 5e5jB-2vc2A:undetectable | 5e5jB-2vc2A:10.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ENT_C_MIYC901_1 (MULTIDRUG EFFLUXPUMP SUBUNITACRB,MULTIDRUGEFFLUX PUMP SUBUNITACRB) |
3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) | 5 / 9 | SER A 77GLY A 302SER A 220ILE A 213ALA A 212 | 006 A 330 (-2.1A)NoneGOL A 332 (-3.7A)NoneNone | 1.39A | 5entC-3qs1A:undetectable | 5entC-3qs1A:19.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5G48_A_1FLA1375_1 (DNA POLYMERASE IIISUBUNIT BETA) |
1qxo | CHORISMATE SYNTHASE (Streptococcuspneumoniae) | 4 / 8 | PRO A 226ILE A 362PRO A 22LEU A 149 | NoneNoneEDO A3006 (-3.9A)None | 0.80A | 5g48A-1qxoA:undetectable | 5g48A-1qxoA:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HQA_A_ACRA705_2 (ALPHA-GLUCOSIDASE) |
3s7w | EIGHT-HEME NITRITEREDUCTASE (Thioalkalivibrionitratireducens) | 4 / 8 | TRP A 329GLU A 365HIS A 300THR A 289 | NoneNoneHEC A1006 (-3.2A)None | 1.47A | 5hqaA-3s7wA:undetectable | 5hqaA-3s7wA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HYR_A_ESTA601_1 (ESTROGEN RECEPTOR) |
3umm | PHOSPHORIBOSYLFORMYLGLYCINAMIDINESYNTHASE (Salmonellaenterica) | 5 / 10 | ALA A 719GLU A 718LEU A 714ARG A 700LEU A 770 | None MG A2006 ( 2.7A)NoneNoneNone | 1.39A | 5hyrA-3ummA:undetectable | 5hyrA-3ummA:11.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3A_A_HQEA303_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 6 / 7 | HIS B2122HIS B2141HIS B2260ASN B2261HIS B2264ALA B2281 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A)None | 0.82A | 5i3aA-4bedB:23.8 | 5i3aA-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3A_A_HQEA303_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 6 / 7 | HIS B2122HIS B2150HIS B2260ASN B2261HIS B2264ALA B2281 | CUO B9006 (-3.2A)CUO B9006 (-3.3A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A)None | 1.48A | 5i3aA-4bedB:23.8 | 5i3aA-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3A_A_HQEA303_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 7 | HIS B2264HIS B2291HIS B2122ALA B2281 | CUO B9006 (-3.2A)CUO B9006 (-3.5A)CUO B9006 (-3.2A)None | 0.90A | 5i3aA-4bedB:23.8 | 5i3aA-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3A_B_HQEB304_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 6 / 7 | HIS B2122HIS B2141HIS B2260ASN B2261HIS B2264ALA B2281 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A)None | 0.81A | 5i3aB-4bedB:23.7 | 5i3aB-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3A_B_HQEB304_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 7 | HIS B2264HIS B2291HIS B2122ALA B2281 | CUO B9006 (-3.2A)CUO B9006 (-3.5A)CUO B9006 (-3.2A)None | 0.88A | 5i3aB-4bedB:23.7 | 5i3aB-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3B_A_HQEA303_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 6 / 7 | HIS B2122HIS B2141HIS B2260ASN B2261HIS B2264ALA B2281 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A)None | 0.83A | 5i3bA-4bedB:23.8 | 5i3bA-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3B_A_HQEA303_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 6 / 7 | HIS B2122HIS B2150HIS B2260ASN B2261HIS B2264ALA B2281 | CUO B9006 (-3.2A)CUO B9006 (-3.3A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A)None | 1.47A | 5i3bA-4bedB:23.8 | 5i3bA-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3B_A_HQEA303_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 7 | HIS B2264HIS B2291HIS B2122ALA B2281 | CUO B9006 (-3.2A)CUO B9006 (-3.5A)CUO B9006 (-3.2A)None | 0.91A | 5i3bA-4bedB:23.8 | 5i3bA-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3B_B_HQEB303_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 5 | HIS B2122HIS B2141HIS B2264ALA B2281 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-3.2A)None | 0.51A | 5i3bB-4bedB:23.8 | 5i3bB-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3B_B_HQEB303_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 5 | HIS B2122HIS B2150HIS B2264ALA B2281 | CUO B9006 (-3.2A)CUO B9006 (-3.3A)CUO B9006 (-3.2A)None | 1.32A | 5i3bB-4bedB:23.8 | 5i3bB-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3B_B_HQEB303_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 5 | HIS B2264HIS B2260HIS B2122ALA B2281 | CUO B9006 (-3.2A)CUO B9006 (-3.2A)CUO B9006 (-3.2A)None | 1.06A | 5i3bB-4bedB:23.8 | 5i3bB-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3B_B_HQEB303_1 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 5 | HIS B2264HIS B2291HIS B2122ALA B2281 | CUO B9006 (-3.2A)CUO B9006 (-3.5A)CUO B9006 (-3.2A)None | 0.93A | 5i3bB-4bedB:23.8 | 5i3bB-4bedB:9.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IAO_C_URFC301_1 (BIFUNCTIONAL PROTEINPYRR) |
2g8s | GLUCOSE/SORBOSONEDEHYDROGENASES (Escherichiacoli) | 3 / 3 | ARG A 323HIS A 16ARG A 34 | EDO A3006 (-4.2A)EDO A3025 (-3.8A)EDO A3025 (-4.0A) | 0.74A | 5iaoC-2g8sA:undetectable | 5iaoC-2g8sA:18.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IAO_F_URFF301_1 (BIFUNCTIONAL PROTEINPYRR) |
2g8s | GLUCOSE/SORBOSONEDEHYDROGENASES (Escherichiacoli) | 3 / 3 | ARG A 323HIS A 16ARG A 34 | EDO A3006 (-4.2A)EDO A3025 (-3.8A)EDO A3025 (-4.0A) | 0.70A | 5iaoF-2g8sA:undetectable | 5iaoF-2g8sA:18.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IGJ_A_CTYA402_2 (MACROLIDE2'-PHOSPHOTRANSFERASE) |
6bms | PALMITOYLTRANSFERASE (Daniorerio) | 4 / 5 | HIS A 142LEU A 137TYR A 155PHE A 158 | ZN A1002 ( 3.1A)NoneNonePLM A1006 (-4.7A) | 1.42A | 5igjA-6bmsA:2.0 | 5igjA-6bmsA:12.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IH0_A_ERYA404_1 (MACROLIDE2'-PHOSPHOTRANSFERASE II) |
1g5b | SERINE/THREONINEPROTEIN PHOSPHATASE (EscherichiavirusLambda) | 4 / 6 | ASP A 20HIS A 139ILE A 183TYR A 200 | MN A1006 (-3.4A) MN A1005 (-3.4A)NoneNone | 1.24A | 5ih0A-1g5bA:0.0 | 5ih0A-1g5bA:22.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JHN_A_SAMA1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 12 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246LYS A1250PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)9HJ A3006 (-4.6A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.58A | 5jhnA-5vsdA:40.3 | 5jhnA-5vsdA:77.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JHN_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.49A | 5jhnB-5vsdA:40.0 | 5jhnB-5vsdA:77.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JIN_A_SAMA1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173HIS A1201TYR A1242PHE A1246LYS A1250PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)9HJ A3006 (-4.6A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.61A | 5jinA-5vsdA:40.4 | 5jinA-5vsdA:77.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JIN_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246LYS A1250PHE A1254CYH A1256 | SAM A3001 (-3.4A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)9HJ A3006 (-4.6A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.62A | 5jinB-5vsdA:40.0 | 5jinB-5vsdA:77.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JIY_A_SAMA1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 12 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246LYS A1250PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)9HJ A3006 (-4.6A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.59A | 5jiyA-5vsdA:40.3 | 5jiyA-5vsdA:77.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JIY_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 12 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246LYS A1250PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)9HJ A3006 (-4.6A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.60A | 5jiyB-5vsdA:39.8 | 5jiyB-5vsdA:77.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JJ0_A_SAMA1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173HIS A1201TYR A1242PHE A1246LYS A1250PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)9HJ A3006 (-4.6A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.60A | 5jj0A-5vsdA:40.3 | 5jj0A-5vsdA:77.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JJ0_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172ASN A1200HIS A1201TYR A1242PHE A1246LYS A1250PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)9HJ A3006 (-4.6A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.61A | 5jj0B-5vsdA:39.9 | 5jj0B-5vsdA:77.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KKL_B_SAMB8009_0 (PUTATIVEUNCHARACTERIZEDPROTEIN,HISTONE H3.1PEPTIDE,ZINC FINGERDOMAIN-CONTAININGPROTEIN) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 5 / 12 | GLY A1137ASN A1200HIS A1201TYR A1242PHE A1246 | SAM A3001 (-3.6A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A) | 0.66A | 5kklB-5vsdA:5.4 | 5kklB-5vsdA:15.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L2T_A_6ZZA900_2 (CYCLIN-DEPENDENTKINASE 6) |
2q27 | OXALYL-COADECARBOXYLASE (Escherichiacoli) | 3 / 3 | LYS A 362GLN A 354ASN A 355 | NoneSO4 A2006 (-4.5A)SO4 A2006 (-3.2A) | 1.05A | 5l2tA-2q27A:undetectable | 5l2tA-2q27A:20.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L5F_B_BO2B201_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-1) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 5 / 11 | HIS A 233THR A 305THR A 258ARG A 59ALA A 308 | ZN A1006 (-3.4A)NoneNoneNoneNone | 1.50A | 5l5fV-2z00A:undetectable5l5fb-2z00A:0.0 | 5l5fV-2z00A:19.315l5fb-2z00A:17.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L5F_N_BO2N201_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-1) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 5 / 11 | HIS A 233THR A 305THR A 258ARG A 59ALA A 308 | ZN A1006 (-3.4A)NoneNoneNoneNone | 1.50A | 5l5fH-2z00A:undetectable5l5fN-2z00A:undetectable | 5l5fH-2z00A:19.315l5fN-2z00A:17.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LSU_B_SAMB1304_1 (HISTONE-LYSINEN-METHYLTRANSFERASENSD2) |
5txk | UBIQUITINCARBOXYL-TERMINALHYDROLASE35,UBIQUITINCARBOXYL-TERMINALHYDROLASE 35 (Homosapiens) | 3 / 3 | ASN A 585TYR A 780CYH A 785 | NoneNone ZN A1006 (-2.3A) | 1.03A | 5lsuB-5txkA:undetectable | 5lsuB-5txkA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M8N_C_MMSC516_1 (5,6-DIHYDROXYINDOLE-2-CARBOXYLIC ACIDOXIDASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 9 | HIS B2122HIS B2141HIS B2260ASN B2261HIS B2264 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A) | 0.78A | 5m8nC-4bedB:21.7 | 5m8nC-4bedB:13.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M8R_A_MMSA511_1 (5,6-DIHYDROXYINDOLE-2-CARBOXYLIC ACIDOXIDASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 7 | HIS B2141HIS B2260ASN B2261HIS B2264 | CUO B9006 (-3.1A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A) | 0.89A | 5m8rA-4bedB:19.5 | 5m8rA-4bedB:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MIG_A_CUA601_0 (LACCASE 2) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | HIS B2141HIS B2150HIS B2122 | CUO B9006 (-3.1A)CUO B9006 (-3.3A)CUO B9006 (-3.2A) | 0.42A | 5migA-4bedB:3.6 | 5migA-4bedB:15.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N5K_A_HAEA306_1 (MACROPHAGEMETALLOELASTASE) |
2vqa | SLL1358 PROTEIN (Synechocystissp.PCC6803) | 4 / 5 | ILE A 272HIS A 283HIS A 329HIS A 285 | None MN A1006 ( 3.4A) MN A1006 (-3.5A) MN A1006 ( 3.5A) | 0.94A | 5n5kA-2vqaA:undetectable | 5n5kA-2vqaA:17.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N5K_A_HAEA306_1 (MACROPHAGEMETALLOELASTASE) |
2vqa | SLL1358 PROTEIN (Synechocystissp.PCC6803) | 5 / 5 | ILE A 272HIS A 329GLU A 290HIS A 285HIS A 283 | None MN A1006 (-3.5A) MN A1006 ( 2.3A) MN A1006 ( 3.5A) MN A1006 ( 3.4A) | 1.05A | 5n5kA-2vqaA:undetectable | 5n5kA-2vqaA:17.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NEK_D_AZMD302_1 (PEPTIDOGLYCANN-ACETYLGLUCOSAMINEDEACETYLASE) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 4 / 8 | ASP A 306HIS A 57ARG A 181HIS A 233 | ZN A1004 (-2.9A) ZN A1004 (-3.4A)None ZN A1006 (-3.4A) | 0.91A | 5nekD-2z00A:undetectable | 5nekD-2z00A:10.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5SXQ_A_NIZA808_1 (CATALASE-PEROXIDASE) |
2g8s | GLUCOSE/SORBOSONEDEHYDROGENASES (Escherichiacoli) | 4 / 8 | ARG A 323GLY A 291GLN A 197LEU A 293 | EDO A3006 (-4.2A)NoneEDO A3006 ( 4.6A)None | 0.96A | 5sxqA-2g8sA:undetectable | 5sxqA-2g8sA:19.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5SXT_A_NIZA807_1 (CATALASE-PEROXIDASE) |
2g8s | GLUCOSE/SORBOSONEDEHYDROGENASES (Escherichiacoli) | 4 / 8 | ARG A 323GLY A 291GLN A 197LEU A 293 | EDO A3006 (-4.2A)NoneEDO A3006 ( 4.6A)None | 1.00A | 5sxtA-2g8sA:undetectable | 5sxtA-2g8sA:19.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5SXT_B_NIZB808_1 (CATALASE-PEROXIDASE) |
2g8s | GLUCOSE/SORBOSONEDEHYDROGENASES (Escherichiacoli) | 4 / 8 | ARG A 323GLY A 291GLN A 197LEU A 293 | EDO A3006 (-4.2A)NoneEDO A3006 ( 4.6A)None | 1.00A | 5sxtB-2g8sA:undetectable | 5sxtB-2g8sA:19.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5T0K_A_SAMA1304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 5 / 12 | GLY A1139TYR A1173HIS A1201TYR A1242PHE A1246 | NoneSAM A3001 (-4.0A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A) | 1.06A | 5t0kA-5vsdA:40.0 | 5t0kA-5vsdA:77.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5T0K_A_SAMA1304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.49A | 5t0kA-5vsdA:40.0 | 5t0kA-5vsdA:77.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5T0K_B_SAMB1304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 10 / 12 | MET A1136GLY A1137TRP A1138SER A1172ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.48A | 5t0kB-5vsdA:37.2 | 5t0kB-5vsdA:77.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5T0K_B_SAMB1304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 9 / 12 | MET A1136SER A1172ASN A1200HIS A1201TYR A1242PHE A1246LYS A1250PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.7A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)9HJ A3006 (-4.6A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.58A | 5t0kB-5vsdA:37.2 | 5t0kB-5vsdA:77.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5T0M_A_SAMA1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246LYS A1250PHE A1254CYH A1256 | SAM A3001 (-3.4A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)9HJ A3006 (-4.6A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.57A | 5t0mA-5vsdA:40.0 | 5t0mA-5vsdA:77.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5T0M_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.50A | 5t0mB-5vsdA:40.4 | 5t0mB-5vsdA:77.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TDZ_A_ADNA905_1 (ATP-CITRATE SYNTHASE) |
5wjm | CADHERIN-23 (Musmusculus) | 4 / 6 | ARG A1889ASP A1892ARG A1895LEU A1891 | None CA A2006 (-3.2A)NoneNone | 1.13A | 5tdzA-5wjmA:undetectable | 5tdzA-5wjmA:11.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTF_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 11 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.28A | 5ttfA-5vsdA:41.1 | 5ttfA-5vsdA:76.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTF_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.27A | 5ttfB-5vsdA:40.5 | 5ttfB-5vsdA:76.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTF_C_SAMC1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172ASN A1200HIS A1201TYR A1242PHE A1246TRP A1247PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)NoneSAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.33A | 5ttfC-5vsdA:40.1 | 5ttfC-5vsdA:76.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTF_D_SAMD1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 11 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.22A | 5ttfD-5vsdA:41.5 | 5ttfD-5vsdA:76.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTG_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.10A | 5ttgA-5vsdA:43.1 | 5ttgA-5vsdA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTG_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 10 / 12 | MET A1136SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256ARG A1257 | SAM A3001 (-3.4A)SAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A)SAM A3001 (-4.3A) | 0.45A | 5ttgA-5vsdA:43.1 | 5ttgA-5vsdA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTG_B_SAMB1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 11 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.11A | 5ttgB-5vsdA:43.6 | 5ttgB-5vsdA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TUY_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.34A | 5tuyA-5vsdA:40.0 | 5tuyA-5vsdA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TUY_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.38A | 5tuyB-5vsdA:39.6 | 5tuyB-5vsdA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TUZ_A_SAMA3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 12 / 12 | MET A1136GLY A1137TRP A1138SER A1172ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256ARG A1257CYH A1258 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A)SAM A3001 (-4.3A) ZN A3005 (-2.3A) | 0.48A | 5tuzA-5vsdA:43.6 | 5tuzA-5vsdA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TUZ_B_SAMB3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 12 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256ARG A1257 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A)SAM A3001 (-4.3A) | 0.43A | 5tuzB-5vsdA:43.3 | 5tuzB-5vsdA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UMW_F_RBFF201_1 (GLYOXALASE/BLEOMYCINRESISANCEPROTEIN/DIOXYGENASE) |
1ta3 | ENDO-1,4-BETA-XYLANASE (Aspergillusnidulans) | 4 / 7 | ARG B 158TYR B 167GLU B 231SER B 230 | EDO B1006 (-4.2A)NoneNoneNone | 1.24A | 5umwA-1ta3B:undetectable5umwF-1ta3B:undetectable | 5umwA-1ta3B:12.885umwF-1ta3B:12.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UUN_A_ACTA310_0 (GLUTATHIONES-TRANSFERASE-LIKEPROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 3 / 3 | GLU A 740HIS A 741ARG A 839 | NoneNoneBCT A3006 (-4.0A) | 0.93A | 5uunA-4yswA:undetectable | 5uunA-4yswA:12.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V0I_A_TRPA402_0 (TRYPTOPHAN--TRNALIGASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 5 / 9 | GLY A 661GLN A 665ASP A 636ILE A 635GLN A 640 | NoneALF A1005 (-3.0A) MG A1006 ( 4.0A)NoneNone | 1.13A | 5v0iA-2xzoA:undetectable | 5v0iA-2xzoA:21.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V0I_B_TRPB402_0 (TRYPTOPHAN--TRNALIGASE) |
2xzo | REGULATOR OFNONSENSE TRANSCRIPTS1 (Homosapiens) | 5 / 9 | GLY A 661GLN A 665ASP A 636ILE A 635GLN A 640 | NoneALF A1005 (-3.0A) MG A1006 ( 4.0A)NoneNone | 1.15A | 5v0iB-2xzoA:undetectable | 5v0iB-2xzoA:21.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V9I_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.23A | 5v9iA-5vsdA:40.8 | 5v9iA-5vsdA:76.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V9I_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 11 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.25A | 5v9iB-5vsdA:40.8 | 5v9iB-5vsdA:76.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V9I_C_SAMC1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 11 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.22A | 5v9iC-5vsdA:41.1 | 5v9iC-5vsdA:76.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V9I_D_SAMD1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173HIS A1201TYR A1242PHE A1246TRP A1247PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)NoneSAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.31A | 5v9iD-5vsdA:40.7 | 5v9iD-5vsdA:76.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V9J_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 12 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256ARG A1257 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A)SAM A3001 (-4.3A) | 0.39A | 5v9jA-5vsdA:43.0 | 5v9jA-5vsdA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V9J_B_SAMB1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.11A | 5v9jB-5vsdA:43.4 | 5v9jB-5vsdA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V9J_B_SAMB1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 8 / 12 | SER A1172TYR A1173HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256ARG A1257 | SAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A)SAM A3001 (-4.3A) | 0.78A | 5v9jB-5vsdA:43.4 | 5v9jB-5vsdA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VLM_B_CVIB301_1 (REGULATORY PROTEINTETR) |
4u9i | PERIPLASMIC [NIFE]HYDROGENASE LARGESUBUNITPERIPLASMIC [NIFE]HYDROGENASE SMALLSUBUNIT (Desulfovibriovulgaris;Desulfovibriovulgaris) | 4 / 8 | GLY S 246ARG L 254TYR L 448ASP L 248 | NoneNoneNoneMPD S2006 ( 4.0A) | 0.87A | 5vlmB-4u9iS:undetectable | 5vlmB-4u9iS:23.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSC_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.38A | 5vscA-5vsdA:40.7 | 5vscA-5vsdA:77.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSC_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.34A | 5vscB-5vsdA:40.9 | 5vscB-5vsdA:77.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSD_A_SAMA3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 12 / 12 | MET A1136GLY A1137TRP A1138SER A1172ASN A1200HIS A1201TYR A1242PHE A1246TRP A1247PHE A1254CYH A1256ARG A1257 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)NoneSAM A3001 ( 4.5A) ZN A3005 ( 2.4A)SAM A3001 (-4.3A) | 0.01A | 5vsdA-5vsdA:45.2 | 5vsdA-5vsdA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSD_B_SAMB3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 12 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256ARG A1257 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A)SAM A3001 (-4.3A) | 0.17A | 5vsdB-5vsdA:43.5 | 5vsdB-5vsdA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSE_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.37A | 5vseA-5vsdA:40.4 | 5vseA-5vsdA:77.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSE_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 11 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A) | 0.36A | 5vseB-5vsdA:40.8 | 5vseB-5vsdA:77.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSF_A_SAMA3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 12 / 12 | MET A1136GLY A1137TRP A1138SER A1172ASN A1200HIS A1201TYR A1242PHE A1246TRP A1247PHE A1254CYH A1256ARG A1257 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)NoneSAM A3001 ( 4.5A) ZN A3005 ( 2.4A)SAM A3001 (-4.3A) | 0.11A | 5vsfA-5vsdA:43.6 | 5vsfA-5vsdA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSF_B_SAMB3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homosapiens) | 12 / 12 | MET A1136GLY A1137TRP A1138SER A1172TYR A1173ASN A1200HIS A1201TYR A1242PHE A1246PHE A1254CYH A1256ARG A1257 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)SAM A3001 ( 4.5A) ZN A3005 ( 2.4A)SAM A3001 (-4.3A) | 0.13A | 5vsfB-5vsdA:43.3 | 5vsfB-5vsdA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUO_B_ACTB804_0 (NITRIC OXIDESYNTHASE, BRAIN) |
4okd | ISOAMYLASE (Chlamydomonasreinhardtii) | 3 / 3 | GLY A 390TRP A 229VAL A 225 | GLC A1005 (-3.2A)GLC A1006 (-4.3A)None | 0.52A | 5vuoB-4okdA:undetectable | 5vuoB-4okdA:17.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WBV_A_SAMA402_1 (HISTONE-LYSINEN-METHYLTRANSFERASEKMT5B) |
3aux | DNA DOUBLE-STRANDBREAK REPAIR RAD50ATPASE (Methanocaldococcusjannaschii) | 3 / 3 | HIS A 979GLU A 947ASN A 34 | NoneNoneADP A1006 ( 4.8A) | 1.01A | 5wbvA-3auxA:undetectable | 5wbvA-3auxA:22.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WBV_B_SAMB402_1 (HISTONE-LYSINEN-METHYLTRANSFERASEKMT5B) |
3aux | DNA DOUBLE-STRANDBREAK REPAIR RAD50ATPASE (Methanocaldococcusjannaschii) | 3 / 3 | HIS A 979GLU A 947ASN A 34 | NoneNoneADP A1006 ( 4.8A) | 1.02A | 5wbvB-3auxA:undetectable | 5wbvB-3auxA:22.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WGQ_B_ESTB601_1 (ESTROGEN RECEPTOR) |
3umm | PHOSPHORIBOSYLFORMYLGLYCINAMIDINESYNTHASE (Salmonellaenterica) | 5 / 10 | ALA A 719GLU A 718LEU A 714ARG A 700LEU A 770 | None MG A2006 ( 2.7A)NoneNoneNone | 1.46A | 5wgqB-3ummA:undetectable | 5wgqB-3ummA:5.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Z0F_B_DAHB98_0 (MELCTYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 11 | HIS B2122HIS B2141HIS B2260ASN B2261HIS B2264 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A) | 0.98A | 5z0fA-4bedB:21.55z0fB-4bedB:undetectable | 5z0fA-4bedB:4.445z0fB-4bedB:4.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Z0G_B_DAHB98_0 (MELCTYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 11 | HIS B2122HIS B2141HIS B2260ASN B2261HIS B2264 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A) | 0.94A | 5z0gA-4bedB:21.25z0gB-4bedB:undetectable | 5z0gA-4bedB:4.445z0gB-4bedB:4.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Z0I_B_DAHB98_0 (MELCTYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 11 | HIS B2122HIS B2141HIS B2260ASN B2261HIS B2264 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A) | 0.94A | 5z0iA-4bedB:23.05z0iB-4bedB:undetectable | 5z0iA-4bedB:4.445z0iB-4bedB:4.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Z0J_B_DAHB98_0 (MELCTYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 11 | HIS B2122HIS B2141HIS B2260ASN B2261HIS B2264 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A) | 0.94A | 5z0jA-4bedB:23.15z0jB-4bedB:undetectable | 5z0jA-4bedB:4.445z0jB-4bedB:4.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Z0K_B_DAHB98_0 (MELCTYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 11 | HIS B2122HIS B2141HIS B2260ASN B2261HIS B2264 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.2A) | 0.92A | 5z0kA-4bedB:23.05z0kB-4bedB:undetectable | 5z0kA-4bedB:4.445z0kB-4bedB:4.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_A_CUA606_0 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 4 | HIS B2122CYH B2139HIS B2141HIS B2150 | CUO B9006 (-3.2A)CUO B9006 (-3.6A)CUO B9006 (-3.1A)CUO B9006 (-3.3A) | 1.14A | 5zrdA-4bedB:30.3 | 5zrdA-4bedB:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_A_CUA606_0 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 4 | HIS B2141CYH B2139HIS B2150HIS B2122 | CUO B9006 (-3.1A)CUO B9006 (-3.6A)CUO B9006 (-3.3A)CUO B9006 (-3.2A) | 1.02A | 5zrdA-4bedB:30.3 | 5zrdA-4bedB:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_A_CUA607_0 (TYROSINASE) |
2vqa | SLL1358 PROTEIN (Synechocystissp.PCC6803) | 3 / 3 | HIS A 283HIS A 329HIS A 285 | MN A1006 ( 3.4A) MN A1006 (-3.5A) MN A1006 ( 3.5A) | 0.46A | 5zrdA-2vqaA:undetectable | 5zrdA-2vqaA:21.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_B_CUB606_0 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 5 | HIS B2122HIS B2141PHE B2146HIS B2150 | CUO B9006 (-3.2A)CUO B9006 (-3.1A)CUO B9006 (-4.7A)CUO B9006 (-3.3A) | 0.93A | 5zrdB-4bedB:28.1 | 5zrdB-4bedB:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_B_CUB606_0 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 5 | HIS B2260HIS B2264PHE B2287HIS B2290HIS B2291 | CUO B9006 (-3.2A)CUO B9006 (-3.2A)CUO B9006 (-4.7A)NoneCUO B9006 (-3.5A) | 0.87A | 5zrdB-4bedB:28.1 | 5zrdB-4bedB:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_B_CUB606_0 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 5 | HIS B2291HIS B2150HIS B2260HIS B2264 | CUO B9006 (-3.5A)CUO B9006 (-3.3A)CUO B9006 (-3.2A)CUO B9006 (-3.2A) | 0.90A | 5zrdB-4bedB:28.1 | 5zrdB-4bedB:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_B_CUB607_0 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 5 | HIS B2122CYH B2139HIS B2141HIS B2150PHE B2287 | CUO B9006 (-3.2A)CUO B9006 (-3.6A)CUO B9006 (-3.1A)CUO B9006 (-3.3A)CUO B9006 (-4.7A) | 1.02A | 5zrdB-4bedB:27.9 | 5zrdB-4bedB:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_B_CUB607_0 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 5 | HIS B2141CYH B2139HIS B2150HIS B2122 | CUO B9006 (-3.1A)CUO B9006 (-3.6A)CUO B9006 (-3.3A)CUO B9006 (-3.2A) | 0.92A | 5zrdB-4bedB:27.9 | 5zrdB-4bedB:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_C_CUC604_0 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 4 | HIS B2260HIS B2264HIS B2290HIS B2291 | CUO B9006 (-3.2A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.5A) | 0.85A | 5zrdC-4bedB:27.6 | 5zrdC-4bedB:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_C_CUC604_0 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 4 | HIS B2291HIS B2150HIS B2260HIS B2264 | CUO B9006 (-3.5A)CUO B9006 (-3.3A)CUO B9006 (-3.2A)CUO B9006 (-3.2A) | 0.86A | 5zrdC-4bedB:27.6 | 5zrdC-4bedB:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_C_CUC605_0 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 5 | HIS B2122CYH B2139HIS B2141HIS B2150PHE B2287 | CUO B9006 (-3.2A)CUO B9006 (-3.6A)CUO B9006 (-3.1A)CUO B9006 (-3.3A)CUO B9006 (-4.7A) | 1.06A | 5zrdC-4bedB:27.6 | 5zrdC-4bedB:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_C_CUC605_0 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 5 | HIS B2141CYH B2139HIS B2150HIS B2122 | CUO B9006 (-3.1A)CUO B9006 (-3.6A)CUO B9006 (-3.3A)CUO B9006 (-3.2A) | 1.03A | 5zrdC-4bedB:27.6 | 5zrdC-4bedB:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_D_CUD606_0 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 5 / 5 | HIS B2122CYH B2139HIS B2141HIS B2150PHE B2287 | CUO B9006 (-3.2A)CUO B9006 (-3.6A)CUO B9006 (-3.1A)CUO B9006 (-3.3A)CUO B9006 (-4.7A) | 1.05A | 5zrdD-4bedB:27.7 | 5zrdD-4bedB:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_D_CUD606_0 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 5 | HIS B2141CYH B2139HIS B2150HIS B2122 | CUO B9006 (-3.1A)CUO B9006 (-3.6A)CUO B9006 (-3.3A)CUO B9006 (-3.2A) | 0.99A | 5zrdD-4bedB:27.7 | 5zrdD-4bedB:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_D_CUD607_0 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 4 | HIS B2260HIS B2264HIS B2290HIS B2291 | CUO B9006 (-3.2A)CUO B9006 (-3.2A)NoneCUO B9006 (-3.5A) | 0.81A | 5zrdD-4bedB:27.6 | 5zrdD-4bedB:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_D_CUD607_0 (TYROSINASE) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 4 / 4 | HIS B2291HIS B2150HIS B2260HIS B2264 | CUO B9006 (-3.5A)CUO B9006 (-3.3A)CUO B9006 (-3.2A)CUO B9006 (-3.2A) | 0.86A | 5zrdD-4bedB:27.6 | 5zrdD-4bedB:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZSF_A_6T0A910_0 (TOLL-LIKE RECEPTOR 7) |
1wmr | ISOPULLULANASE (Aspergillusniger) | 4 / 7 | THR A 383LEU A 411ILE A 461THR A 462 | NoneNAG A1006 (-3.6A)NoneNAG A1006 ( 4.9A) | 1.03A | 5zsfA-1wmrA:1.55zsfB-1wmrA:1.5 | 5zsfA-1wmrA:7.795zsfB-1wmrA:7.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AYC_A_1YNA502_2 (PROTEIN CYP51) |
5l0v | PROTEINO-GLUCOSYLTRANSFERASE 1 (Homosapiens) | 4 / 7 | VAL A 328PRO A 220LEU A 223LEU A 318 | NoneNoneMPD A1006 ( 4.4A)MPD A1006 ( 4.6A) | 1.09A | 6aycA-5l0vA:undetectable | 6aycA-5l0vA:12.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DCH_A_ACTA401_0 (SCOE PROTEIN) |
2z00 | DIHYDROOROTASE (Thermusthermophilus) | 4 / 5 | THR A 258HIS A 55ASP A 147HIS A 57 | None ZN A1004 (-3.2A) ZN A1006 ( 2.5A) ZN A1004 (-3.4A) | 1.16A | 6dchA-2z00A:undetectable | 6dchA-2z00A:21.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DWD_B_GLYB709_0 (DEOXYNUCLEOSIDETRIPHOSPHATETRIPHOSPHOHYDROLASESAMHD1) |
2bwa | ENDOGLUCANASE (Rhodothermusmarinus) | 4 / 5 | GLY A 53ASN A 52ASP A 51ARG A 100 | NoneNoneNoneGOL A1006 (-2.7A) | 1.37A | 6dwdB-2bwaA:undetectable6dwdD-2bwaA:undetectable | 6dwdB-2bwaA:16.826dwdD-2bwaA:16.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ECT_A_SAMA1300_0 (STIE PROTEIN) |
1k8q | TRIACYLGLYCEROLLIPASE, GASTRIC (Canislupus) | 5 / 12 | ASN A 73LEU A 179GLY A 155GLY A 151SER A 99 | BOG A1006 ( 4.5A)NoneNoneNoneNone | 1.06A | 6ectA-1k8qA:undetectable | 6ectA-1k8qA:20.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ESM_A_PZEA307_1 (MATRIXMETALLOPROTEINASE-9,MATRIXMETALLOPROTEINASE-9) |
4bed | HEMOCYANIN KLH1 (Megathuracrenulata) | 3 / 3 | TYR B2153HIS B2150PHE B2287 | NoneCUO B9006 (-3.3A)CUO B9006 (-4.7A) | 1.06A | 6esmA-4bedB:undetectable | 6esmA-4bedB:4.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6HU9_C_PCFC607_0 (CYTOCHROME B) |
4pd4 | CYTOCHROME B (Saccharomycescerevisiae) | 10 / 10 | TRP C 29PHE C 94MET C 97ALA C 98TYR C 102TYR C 103THR C 317PHE C 326PHE C 327VAL C 330 | 3PH C4006 (-3.6A)3PH C4006 ( 4.8A)3PH C4006 ( 4.1A)3PH C4006 (-3.6A)3PH C4006 (-3.3A)3PH C4006 (-4.9A)3PH C4006 (-3.3A)None3PH C4006 ( 4.9A)3PH C4006 ( 4.4A) | 0.35A | 6hu9C-4pd4C:5.6 | 6hu9C-4pd4C:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6HU9_N_PCFN606_0 (CYTOCHROME B) |
4pd4 | CYTOCHROME B (Saccharomycescerevisiae) | 12 / 12 | TRP C 29PHE C 94MET C 95MET C 97ALA C 98TYR C 102TYR C 103THR C 317PHE C 327VAL C 330VAL C 334TYR C 359 | 3PH C4006 (-3.6A)3PH C4006 ( 4.8A)None3PH C4006 ( 4.1A)3PH C4006 (-3.6A)3PH C4006 (-3.3A)3PH C4006 (-4.9A)3PH C4006 (-3.3A)3PH C4006 ( 4.9A)3PH C4006 ( 4.4A)NoneNone | 0.38A | 6hu9N-4pd4C:undetectable | 6hu9N-4pd4C:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6IEY_A_CLMA401_0 (ESTERASE) |
3tej | ENTEROBACTINSYNTHASE COMPONENT F (Escherichiacoli) | 5 / 11 | ILE A 980ALA A1009LEU A 987GLY A1004ALA A 997 | NoneUF0 A1006 ( 3.3A)NoneNoneNone | 1.20A | 6ieyA-3tejA:15.16ieyB-3tejA:15.3 | 6ieyA-3tejA:25.626ieyB-3tejA:25.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MN4_B_AM2B301_0 (AMINOGLYCOSIDEN(3)-ACETYLTRANSFERASE, AAC(3)-IVA) |
5w1d | PROTOCADHERIN-15 (Musmusculus) | 4 / 8 | ARG A 450GLU A 385ASP A 480GLU A 517 | None CA A1007 (-2.9A) CA A1007 (-2.7A) K A1006 (-2.8A) | 1.03A | 6mn4B-5w1dA:undetectable | 6mn4B-5w1dA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MN5_D_LLLD301_0 (AMINOGLYCOSIDEN(3)-ACETYLTRANSFERASE, AAC(3)-IVA) |
5w1d | PROTOCADHERIN-15 (Musmusculus) | 4 / 6 | ASP A 449ARG A 450ASP A 480GLU A 517 | NoneNone CA A1007 (-2.7A) K A1006 (-2.8A) | 1.30A | 6mn5D-5w1dA:undetectable | 6mn5D-5w1dA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MN5_E_LLLE301_0 (AMINOGLYCOSIDEN(3)-ACETYLTRANSFERASE, AAC(3)-IVA) |
5w1d | PROTOCADHERIN-15 (Musmusculus) | 4 / 7 | ARG A 450GLU A 385ASP A 480GLU A 517 | None CA A1007 (-2.9A) CA A1007 (-2.7A) K A1006 (-2.8A) | 1.28A | 6mn5E-5w1dA:undetectable | 6mn5E-5w1dA:20.00 |